Plant protein-based microcapsules

Abstract

The present invention relates to a new method for preparing vegetable protein-based microcapsules. The vegetable protein-based microcapsules are also the subject of the present invention. Perfume compositions and consumer products, especially perfumed consumer products in the form of home care or personal care products, comprising said microcapsules are also part of the present invention.

Description

[Technical field]

[0001] The present invention relates to a new method for preparing vegetable protein-based microcapsules. The vegetable protein-based microcapsules are also the subject of the present invention. Perfume compositions and consumer products, especially perfumed consumer products in the form of home care or personal care products, comprising said microcapsules are also part of the present invention.

[0002] 2. Background of the Invention One of the problems faced by the fragrance industry is that the olfactory benefits provided by odoriferous compounds are lost relatively quickly due to their volatility, especially the volatility of "top notes". In order to control the release rate of volatile substances, delivery systems such as perfume-containing microcapsules need to protect the core payload and release it later when triggered. A key requirement by the industry for these systems is to withstand suspension in a challenging base without physical dissociation or decomposition. This is referred to as the stability of the delivery system. For example, perfumed personal and household cleaners that contain high levels of aggressive surfactant detergents are very challenging for the stability of microcapsules.

[0003] Polyurea and polyurethane based microcapsule slurries are widely used, for example, in the perfume industry, since they provide a long-lasting pleasant olfactory effect after application on various substrates. These microcapsules have been widely disclosed in the prior art (see, for example, WO 2007 / 004166 or EP 2300146).

[0004] In addition to performance in terms of stability and olfactory performance, consumer demand for environmentally friendly delivery systems is becoming increasingly important and is driving the development of new delivery systems.

[0005] There is therefore still a need to provide new microcapsules using more environmentally friendly materials, without compromising the performance of the microcapsules in terms of stability, especially in hostile media such as consumer product bases, and also in providing good performance in terms of delivery of active ingredients, e.g. olfactory performance in the case of perfumery ingredients.

[0006] The present invention proposes a solution to the above mentioned problems by providing new vegetable protein based microcapsules and a method for preparing said microcapsules.

[0007] Summary of the Invention It has now been found that by reacting a multifunctional monomer (e.g., acyl chloride) and, optionally, a reactant (e.g., at least one amino compound) in the presence of a plant-derived protein, it is possible to obtain high-performance core-shell microcapsules encapsulating hydrophobic materials. Thus, the microcapsules of the present invention provide a solution to the above-mentioned problems, since they allow the preparation of environmentally friendly microcapsules with the desired stability in a cumbersome base.

[0008] In a first aspect, the present invention provides a core-shell microcapsule comprising: a core comprising a hydrophobic material, preferably a perfume oil; - a polymer shell comprising a protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, broad bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof; The core-shell microcapsule comprises:

[0009] Another object of the present invention is a core-shell microcapsule slurry comprising at least one microcapsule, the microcapsule being a core comprising a hydrophobic material, preferably a perfume oil; - a polymer shell comprising a protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, broad bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof; The core-shell microcapsule slurry comprises:

[0010] Another object of the present invention is a method for preparing a core-shell microcapsule slurry, comprising the steps of: a) preparing an oil phase comprising a hydrophobic material, preferably a fragrance, to form an oil phase; b) dispersing the oil phase obtained in step a) in an aqueous phase to form an oil-in-water emulsion; c) carrying out a curing step to form microcapsules in the form of a slurry. Including, A multifunctional monomer is added to the oil phase and / or the water phase; A protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, faba bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof is added to the oil phase and / or the water phase.

[0011] The present invention also relates to perfumed consumer products and flavoured edible products comprising the microcapsules defined above.

[0012] Detailed Description of the Invention Unless otherwise stated, percentages (%) are intended to refer to percentages by weight of the composition.

[0013] "Active ingredient" means a single compound or a combination of ingredients.

[0014] By "fragrance or flavor oil" is meant a single fragrance or flavoring compound or a mixture of several fragrance or flavoring compounds.

[0015] "Consumer product" or "final product" means a manufactured item that is ready for distribution, sale and use by a consumer.

[0016] For the sake of clarity, the expression "dispersion" in the present invention means a system in which particles are dispersed in a continuous phase of different composition, and specifically includes a suspension or an emulsion.

[0017] By "microcapsule" or the like in the present invention is meant a core-shell microcapsule having a particle size distribution in the micron range (e.g., mean diameter (d(v,0.5)) comprised between about 1 and 3000 microns, preferably between 1 and 500 microns) and comprising an outer solid polymer shell and an inner continuous oil phase surrounded by the outer shell. According to a particular embodiment, the polymer shell is a polyamide-based shell.

[0018] "Microcapsule slurry" means microcapsules dispersed in a liquid. According to one embodiment, the slurry is an aqueous slurry, i.e., the microcapsules are dispersed in an aqueous phase.

[0019] By "amino compound" is to be understood a compound which has at least two reactive amine groups.

[0020] By "polyamide-based microcapsule", "polyamide-based core-shell microcapsule" or "polyamide-based shell" is meant that the shell of the microcapsule comprises a polyamide material. The expression "polyamide-based microcapsule" may also encompass a shell made of a polyamide material and another material, for example a composite material comprising a protein as defined in the present invention.

[0021] "Polyamide-based microcapsules" and "polyamide microcapsules" are used interchangeably in the present invention. "Polyamide-based shells" and "polyamide shells" are used interchangeably in the present invention.

[0022] "Multifunctional monomer" refers to a molecule that chemically reacts or bonds as a unit to form a polymer or supramolecular polymer. The multifunctional monomer of the present invention has at least two functional groups that can react or bond with functional groups of other components and / or polymerize to form a polymer shell.

[0023] It has now been found possible to obtain core-shell microcapsules, preferably polyamide-based microcapsules, which have good overall performance in a troublesome base.

[0024] Core-shell microcapsules A first subject of the present invention is a core-shell microcapsule, a core comprising a hydrophobic material, preferably a fragrance; - a polymer shell comprising a protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, broad bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof; The core-shell microcapsule comprises:

[0025] According to one embodiment, the proteins in the polymer shell are crosslinked.

[0026] According to one embodiment, the proteins in the polymer shell are partially cross-linked.

[0027] According to one embodiment, the proteins in the polymer shell are not cross-linked.

[0028] According to one embodiment, the polymer shell comprises polymerized multifunctional monomers.

[0029] Hydrophobic Materials According to one embodiment, the core is an oily core.

[0030] A hydrophobic material according to the present invention can be an "inert" material such as a solvent or an active ingredient.

[0031] "Hydrophobic material" means a hydrophobic material that forms a two-phase dispersion when mixed with water. Hydrophobic materials are typically liquids at about 20°C.

[0032] According to one embodiment, the hydrophobic material is a hydrophobic active ingredient.

[0033] When the hydrophobic material is an active ingredient, the active ingredient is preferably selected from the group consisting of flavors, flavor ingredients, fragrances, fragrance ingredients, dietary supplements, cosmetics, pest control agents, biocidal active agents and mixtures thereof.

[0034] According to a particular embodiment, the hydrophobic material comprises a phase change material (PCM).

[0035] According to certain embodiments, the hydrophobic material comprises a mixture of a fragrance and another ingredient selected from the group consisting of dietary supplements, cosmetics, pest control agents and biocidal actives.

[0036] According to certain embodiments, the hydrophobic material comprises a mixture of a biocidal active and another ingredient selected from the group consisting of fragrances, nutraceuticals, cosmetics, and pest control agents.

[0037] According to certain embodiments, the hydrophobic material comprises a mixture of a pesticide and another ingredient selected from the group consisting of fragrances, nutraceuticals, cosmetics, and biocide actives.

[0038] According to certain embodiments, the hydrophobic material comprises a fragrance.

[0039] According to a particular embodiment, the hydrophobic material consists of a fragrance.

[0040] According to a particular embodiment, the hydrophobic material consists of a biocidal active agent.

[0041] According to certain embodiments, the hydrophobic material comprises a pesticide.

[0042] By "perfume" (or also "perfume oil") herein is meant an ingredient or composition that is liquid at about 20°C. According to any one of the above embodiments, said perfume oil may be a perfuming ingredient alone or a mixture of ingredients in the form of a perfume composition. By "perfuming ingredient" herein is meant a compound that is used for the primary purpose of imparting or modulating an odor. In other words, such an ingredient, in order to be considered a perfuming ingredient, must not only have an odor, but must be recognized by the skilled artisan as being at least capable of imparting or modifying the odor of the composition in a positive or pleasant way. For the purposes of the present invention, perfume oil also includes combinations of perfuming ingredients with any substance that both improves, enhances or modifies the delivery of the perfuming ingredient, such as perfume precursors, modifiers, emulsions or dispersions, and combinations that provide additional benefits beyond modifying or imparting an odor, such as persistence, blooming, deodorization, antibacterial action, microbial stability, pest control.

[0043] The nature and type of perfume ingredients present in the oil phase do not require a more detailed description here, and are in any case not comprehensive, and those skilled in the art can select them based on their general knowledge according to the intended use or application and the desired organoleptic effect.Generally, these perfume ingredients belong to various chemical classes, such as alcohols, aldehydes, ketones, esters, ethers, acetates, nitriles, terpenoids, nitrogen-containing or sulfur-containing heterocyclic compounds, and essential oils (e.g. thyme oil), and said perfume co-ingredients can be of natural or synthetic origin.Many of these co-ingredients are described in any case in reference literature, for example in the book Perfume and Flavor Chemicals, 1969, Montclair, New Jersey, USA, by S. Arctander, or its more recent editions, or other treatises of the same kind, and in the abundant patent literature in the field of perfumery.

[0044] Mention may in particular be made of perfuming ingredients commonly used in perfume formulations such as: - aldehyde components: decanal, dodecanal, 2-methyl-undecanal, 10-undecenal, octanal, nonanal and / or nonenal; - Aromatic Herbal Ingredients: Eucalyptus Oil, Camphor, Eucalyptol, 5-Methyltricyclo[6.2.1.0 2,7 ]undecane-4-one, 1-methoxy-3-hexanethiol, 2-ethyl-4,4-dimethyl-1,3-oxathiane, 2,2,7 / 8,9 / 10-tetramethylspiro[5.5]undec-8-en-1-one, menthol and / or α-pinene; - Balsam components: coumarin, ethyl vanillin and / or vanillin; - Citrus ingredients: dihydromyrcenol, citral, orange oil, linalyl acetate, citronellyl nitrile, orange terpenes, limonene, 1-p-menthen-8-yl acetate and / or 1,4(8)-p-menthadiene; - Floral components: Methyl dihydrojasmonate, linalool, citronellol, phenylethanol, 3-(4-tert-butylphenyl)-2-methylpropanal, hexylcinnamaldehyde, benzyl acetate, benzyl salicylate, tetrahydro-2-isobutyl-4-methyl-4(2H)-pyranol, beta-ionone, methyl 2-(methylamino)benzoate, (E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, (1E)-1-(2 ,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one, 1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one, (2E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one, (2E)-1-[2,6,6-trimethyl-3-cyclohexen-1-yl]-2-buten-1-one, (2E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one, 3-(3,3 / 1,1-dimethyl-5-indanyl)propanal, 2,5-dimethyl-2-indanethanol, 2,6,6-trimethyl-3-cyclohexene-1-carboxylate, 3-(4,4-dimethyl-1-cyclohexen-1-yl)propanal, hexyl salicylate, 3,7-dimethyl-1,6-nonadien-3-ol, 3-(4-isopropylphenyl)-2-methylpropanal, vergyl acetate, geraniol, p-mentha-1-en-8-ol, 4-(1,1-dimethylphenyl)propanal, 1,2-dimethylphenylacetate, 1,3-dimethylphenylacetate, 1,4-dimethylphenylacetate, 1,5-dimethylphenylacetate, 1,6-dimethylphenylacetate ...6-dimethylphenylacetate, 1,7-dimethylphenylacetate, 1,6-dimethylphenylacetate, 1,7-dimethylphenylacetate, 1,8-dimethylphenylacetate, 1,8-dimethylphenylacetate, 1,9-dimethylphenylacetate, 1,9-dimethylphenylacetate, 1,9-dimethylphenylacetate, 1,9-dimethylphenylacetate, 1,9-dimethylphenylacetate, 1,9-dimethylphenylacetate, 1,9-dimethylphenylacetate, 1,9-dimethylphenylacetate, 1,9-dimethylphenylacetate, 1,9 ethylethyl)-1-cyclohexyl acetate, 1,1-dimethyl-2-phenylethyl acetate, 4-cyclohexyl-2-methyl-2-butanol, amyl salicylate, cis-high methyl dihydrojasmonate, 3-methyl-5-phenyl-1-pentanol, vergyl proprionate, geranyl acetate, tetrahydrolinalool, cis-7-p-menthanol, propyl (S)-2-(1,1-dimethylpropoxy)propanoate, 2-methoxynaphthalene, 2,2,2-Trichloro-1-phenylethyl acetate, 4 / 3-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carbaldehyde, amylcinnamaldehyde, 8-decen-5-olide, 4-phenyl-2-butanone, isononyl acetate, 4-(1,1-dimethylethyl)-1-cyclohexyl acetate, vergyl isobutyrate and / or methyl ionone isomeric mixture;, - Fruity ingredients: gamma-undecalactone, 2,2,5-trimethyl-5-pentylcyclopentanone, 2-methyl-4-propyl-1,3-oxathiane, 4-decanolide, ethyl 2-methylpentanoate, hexyl acetate, ethyl 2-methylbutanoate, gamma-nonalactone, allyl heptanoate, 2-phenoxyethyl isobutyrate, ethyl 2-methyl-1,3-dioxolane-2-acetate, diethyl 1,4-cyclohexanedicarboxylate, 3-methyl-2-hexen-1-yl acetate, 1-[3,3-dimethylcyclohexyl]ethyl[3-ethyl-2-oxiranyl]acetate, and / or diethyl 1,4-cyclohexanedicarboxylate; - Green ingredients: 2-methyl-3-hexanone (E)-oxime, 2,4-dimethyl-3-cyclohexene-1-carbaldehyde, 2-tert-butyl-1-cyclohexyl acetate, styralyl acetate, allyl (2-methylbutoxy)acetate, 4-methyl-3-decen-5-ol, diphenyl ether, (Z)-3-hexen-1-ol and / or 1-(5,5-dimethyl-1-cyclohexen-1-yl)-4-penten-1-one; - Musk ingredients: 1,4-dioxa-5,17-cycloheptadecanedione, (Z)-4-cyclopentadecen-1-one, 3-methylcyclopentadecanone, 1-oxa-12-cyclohexadecen-2-one, 1-oxa-13-cyclohexadecen-2-one, (9Z)-9-cycloheptadecen-1-one, 2-{(1S)-1-[(1R)-3,3-dimethylcyclohexyl]ethoxy}-2-oxoethylpropionate, 3-methyl-5-cyclo pentadecen-1-one, 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene, (1S,1'R)-2-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy]-2-methylpropylpropanoate, oxacyclohexadecan-2-one and / or (1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methylpropanoate; - Woody Ingredients: 1-[(1RS,6SR)-2,2,6-trimethylcyclohexyl]-3-hexanol, 3,3-dimethyl-5-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-2-ol, 3,4'-dimethylspiro[oxirane-2,9'-tricyclo[6.2.1.02,7]undec[4]ene, (1-ethoxyethoxy)cyclododecane, 2,2,9,11-tetramethylspiro[5.5]undec-8-en-1-yl acetate, 1-(octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)-1-ethanone, Patchouli Oil, terpene fraction of patchouli oil, Clearwood®, (1'R,E)-2-ethyl-4-(2',2',3'-trimethyl-3'-cyclopenten-1'-yl)-2-buten-1-ol, 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol, methyl cedryl ketone, 5-(2,2,3-trimethyl-3-cyclopentenyl)-3-methylpentan-2-ol, 1-(2,3,8,8-tetramethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)ethan-1-one and / or isobornyl acetate; - other ingredients (e.g. amber, powdery spicy or watery): dodecahydro-3a,6,6,9a-tetramethyl-naphtho[2,1-b]furan and any stereoisomers thereof, heliotropin, anisaldehyde, eugenol, cinnamaldehyde, clove oil, 3-(1,3-benzodioxol-5-yl)-2-methylpropanal, 7-methyl-2H-1,5-benzodioxepin-3(4H)-one, 2,5,5-trimethyl-1,2,3,4,4a,5,6,7-octahydro-2-naphthalenol, 1-phenylvinyl acetate, 6-methyl-7-oxa-1-thia-4-azaspiro[4.4]nonane and / or 3-(3-isopropyl-1-phenyl)butanal.

[0045] It is also understood that the above ingredients may be compounds known to provide a controlled release of various types of perfuming compounds, also known as properfumes or profragrances. Non-limiting examples of suitable properfumes include 4-(dodecylthio)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-butanone, 4-(dodecylthio)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butanone, 3-(dodecylthio)-1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-1-butanone, 2-(dodecylthio)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-butanone, 3-(dodecylthio)-1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-1-butanone, 2-(dodecylthio)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-butanone, 3-(dodecylthio)-1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-1-butanone, 3-(dodecylthio)-4-(2,6,6-trimethyl-2 ... O)Octan-4-one, 2-phenylethyloxo(phenyl)acetate, 3,7-dimethylocta-2,6-dien-1-yloxo(phenyl)acetate, (Z)-hex-3-en-1-yloxo(phenyl)acetate, 3,7-dimethyl-2,6-octadien-1-ylhexadecanoate, bis(3,7-dimethylocta-2,6-dien-1-yl)succinate, (2 -((2-methylundec-1-en-1-yl)oxy)ethyl)benzene, 1-methoxy-4-(3-methyl-4-phenethoxybut-3-en-1-yl)benzene, (3-methyl-4-phenethoxybut-3-en-1-yl)benzene, 1-(((Z)-hex-3-en-1-yl)oxy)-2-methylundec-1-ene, (2-((2-methylundec-1-en-1-yl) )oxy)ethoxy)benzene, 2-methyl-1-(octan-3-yloxy)undec-1-ene, 1-methoxy-4-(1-phenethoxyprop-1-en-2-yl)benzene, 1-methyl-4-(1-phenethoxyprop-1-en-2-yl)benzene, 2-(1-phenethoxyprop-1-en-2-yl)naphthalene, (2-phenethoxyvinyl)benzene, 2-(1-((3,7-dimethyloct-6-en-1-yl)oxy)prop-1-en-2-yl)naphthalene, (2-((2-pentylcyclopentylidene)methoxy)ethyl)benzene, 4-allyl-2-methoxy-1-((2-methoxy-2-phenylvinyl)oxy)benzene, (2-((2-heptylcyclopentylidene)methoxy)ethyl)benzene, 1-isopropyl-4-methyl-2-((2-pentylcyclopentylidene)methoxy)benzene, 2-methoxy-1-((2-pentylcyclopentylidene)methoxy)-4-propylbenzene, 3-methoxy-4-((2-methoxy-2-phenylvinyl)oxy)benzaldehyde, 4-((2-(hexyloxy)-2-phenylvinyl)oxy)-3-methoxybenzaldehyde or mixtures thereof.

[0046] The perfuming ingredients can be dissolved in solvents currently used in the perfume industry. The solvent is preferably not alcohol. Examples of such solvents are diethyl phthalate, isopropyl myristate, Abalyn® (a rosin-based resin available from Eastman), benzyl benzoate, ethyl citrate, triethyl citrate, limonene or other terpenes, or isoparaffins. Preferably, the solvent is very hydrophobic and highly sterically hindered, such as Abalyn® or benzyl benzoate. Preferably, the perfume contains less than 30% solvent. More preferably, the perfume contains less than 20% and even more preferably less than 10% solvent, all these percentages being defined by weight relative to the total weight of the perfume. Most preferably, the perfume is essentially solvent-free.

[0047] Preferred perfuming ingredients are those with high steric hindrance, in particular those from one of the following groups: - Group 1: Perfuming ingredients containing a cyclohexane, cyclohexene, cyclohexanone or cyclohexenone ring substituted with at least one linear or branched C1-C4 alkyl or alkenyl substituent; - Group 2: Perfuming ingredients containing a cyclopentane, cyclopentene, cyclopentanone or cyclopentenone ring substituted with at least one linear or branched C4-C8 alkyl or alkenyl substituent; - group 3: perfuming ingredients containing a phenyl ring or a cyclohexane, cyclohexene, cyclohexanone or cyclohexenone ring substituted with at least one linear or branched C5-C8 alkyl or alkenyl substituent or substituted with at least one phenyl substituent and optionally one or more linear or branched C1-C3 alkyl or alkenyl substituents; - Group 4: Perfuming ingredients containing at least two fused or linked C5 and / or C6 rings; - Group 5: Odour components containing camphor-like ring structures; - Group 6: at least one C7-C 20 Fragrance components containing ring structures; - Group 7: Perfuming ingredients having a logP value of more than 3.5 and containing at least one tert-butyl or at least one trichloromethyl substituent; Examples of members of each of these groups are as follows: - group 1: 2,4-dimethyl-3-cyclohexene-1-carbaldehyde (supplier: Firmenich SA, Geneva, Switzerland), isocyclocitral, menthone, isomenthone, methyl 2,2-dimethyl-6-methylene-1-cyclohexanecarboxylate (supplier: Firmenich SA, Geneva, Switzerland), nerone, terpineol, dihydroterpineol, terpenyl acetate, dihydroterpenyl acetate, dipentene, eucalyptol, hexylates, rose oxide, (S)-1,8-p-menthadien-7-ol (supplier: Firmenich SA, Geneva, Switzerland), 1-p-menthen-4-ol, (1RS,3RS,4SR)-3-p-menthanyl acetate, (1R,2S,4R)-4,6,6-trimethyl-bicyclo[3,1,1]heptan-2-ol, tetrahydro-4-methyl-2-phenyl-2H-pyran (Supplied by: Firmenich SA, Geneva, Switzerland), cyclohexyl acetate, cyclanol acetate, 1,4-cyclohexanediethyl dicarboxylate (Supplied by: Firmenich SA, Geneva, Switzerland), (3RS,3aRS,6SR,7ASR)-perhydro-3,6-dimethyl-benzo[B]furan-2-one (Supplied by: Firmenich SA, Geneva, Switzerland), ((6R)-perhydro-3,6-dimethyl-benzo[B]furan-2-one (supplied by Firmenich SA, Geneva, Switzerland), 2,4,6-trimethyl-4-phenyl-1,3-dioxane, 2,4,6-trimethyl-3-cyclohexene-1-carbaldehyde; - group 2: (E)-3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol (supplied by Givaudan SA, Vernier, Switzerland), (1'R,E)-2-ethyl-4-(2',2',3'-trimethyl-3'-cyclopenten-1'-yl)-2-buten-1-ol (supplied by Firmenich SA, Geneva, Switzerland), (1'R,E)-3,3-dimethyl-5-(2',2',3'-trimethyl-3'-cyclopenten-1'-yl)-4-penten-2-ol (supplied by Firmenich SA, Geneva, Switzerland), 2-heptylcyclopentanone, methyl-cis-3-oxo-2-pentyl-1-cyclopentane acetate (supplied by Firmenich SA, Geneva, Switzerland), 2,2,5-trimethyl-5-pentyl-1-cyclopentanone (supplied by Firmenich SA, Geneva, Switzerland), 3,3-dimethyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol (supplied by Firmenich SA, Geneva, Switzerland), 3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-pentanol (supplied by Givaudan SA, Vernier, Switzerland); - group 3: damascone, 1-(5,5-dimethyl-1-cyclohexen-1-yl)-4-penten-1-one (supplied by Firmenich SA, Geneva, Switzerland), (1'R)-2-[2-(4'-methyl-3'-cyclohexen-1'-yl)propyl]cyclopentanone, α-ionone, β-ionone, damascenone, a mixture of 1-(5,5-dimethyl-1-cyclohexen-1-yl)-4-penten-1-one and 1-(3,3-dimethyl-1-cyclohexen-1-yl)-4-penten-1-one (supplied by Firmenich SA, Geneva, Switzerland), 1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one (supplied by Firmenich SA, Geneva, Switzerland); SA, Geneva, Switzerland), (1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methylpropanoate (Supplied by: Firmenich SA, Geneva, Switzerland), 2-tert-butyl-1-cyclohexyl acetate (Supplied by: International Flavors and Fragrances, USA), 1-(2,2,3,6-tetramethyl-cyclohexyl)-3-hexanol (Supplied by: Firmenich SA, Geneva, Switzerland), trans-1-(2,2,6-trimethyl-1-cyclohexyl)-3-hexanol (Supplied by: Firmenich SA, Geneva, Switzerland), (E)-3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, terpenyl isobutyrate, 4-(1,1-dimethylethyl)-1-cyclohexyl acetate (Supplied by Firmenich SA, Geneva, Switzerland), 8-Methoxy-1-p-menthene, (1S,1'R)-2-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy]-2-methylpropylpropanoate (Supplied by Firmenich SA, Geneva, Switzerland).Switzerland), para-tert-butylcyclohexanone, menthenethiol, 1-methyl-4-(4-methyl-3-pentenyl)-3-cyclohexene-1-carbaldehyde, allyl cyclohexylpropionate, cyclohexyl salicylate, 2-methoxy-4-methylphenyl methyl carbonate, ethyl 2-methoxy-4-methylphenyl carbonate, 4-ethyl-2-methoxyphenyl methyl carbonate;, - Group 4: Methyl cedryl ketone (Supplier: International Flavors and Fragrances, USA), (1RS,2SR,6RS,7RS,8SR)-tricyclo[5.2.1.0 2,6 ]dec-3-en-8-yl 2-methylpropanoate and (1RS,2SR,6RS,7RS,8SR)-tricyclo[5.2.1.0 2,6]dec-4-en-8-yl 2-methylpropanoate, vetiverol, vetiveron, 1-(octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)-1-ethanone (supplied by International Flavors and Fragrances, USA), (5RS,9RS,10SR)-2,6,9,10-tetramethyl-1-oxaspiro[4.5]deca-3,6-diene and (5RS,9SR,10RS) isomer, 6-ethyl-2,10,10-trimethyl-1-oxaspiro[4.5]deca-3,6-diene, 1,2,3,5,6,7-hexahydro-1,1,2,3,3-pentamethyl-4-indenone (supplied by International Flavors and Fragrances, USA). Fragrances, USA), a mixture of 3-(3,3-dimethyl-5-indanyl)propanal and 3-(1,1-dimethyl-5-indanyl)propanal (Supplied by Firmenich SA, Geneva, Switzerland), 3',4-dimethyl-tricyclo[6.2.1.0(2,7)]undec-4-ene-9-spiro-2'-oxirane (Supplied by Firmenich SA, Geneva, Switzerland), 9 / 10-ethyldiene-3-oxatricyclo[6.2.1.0(2,7)]undecane, (perhydro-5,5,8A-trimethyl-2-naphthalenyl acetate (Supplied by Firmenich SA, Geneva, Switzerland), octalinol, (dodecahydro-3a,6,6,9a-tetramethyl-naphtho[2,1-b]furan (Supplied by Firmenich SA, Geneva, Switzerland), tricyclo[5.2.1.0(2,6)]dec-3-en-8-yl acetate and tricyclo[5.2.1.0(2,6)]dec-4-en-8-yl acetate, and tricyclo[5.2.1.0(2,6)]dec-3-en-8-yl propanoate and tricyclo[5.2.1.0(2,6)]dec-4-en-8-yl propanoate, (+)-(1S,2S,3S)-2,6,6-trimethyl-bicyclo[3.1.1]heptane-3-spiro-2'-cyclohexen-4'-one; - Group 5: camphor, borneol, isobornyl acetate, 8-isopropyl-6-methyl-bicyclo[2.2.2]oct-5-ene-2-carbaldehyde, pinene, camphene, 8-methoxycedrane, (8-methoxy-2,6,6,8-tetramethyl-tricyclo[5.3.1.0(1,5)]undecane (supplier: Firmenich SA, Geneva, Switzerland), cedrene, cedrenol, cedrol, 9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecane-4-one and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecane-4-one. 2,7 ]undecane-4-one (supplied by Firmenich SA, Geneva, Switzerland), 3-methoxy-7,7-dimethyl-10-methylene-bicyclo[4.3.1]decane (supplied by Firmenich SA, Geneva, Switzerland); - group 6: (trimethyl-13-oxabicyclo-[10.1.0]-trideca-4,8-diene (supplier: Firmenich SA, Geneva, Switzerland), 9-hexadecen-16-olide (supplier: Firmenich SA, Geneva, Switzerland), pentadecenolide (supplier: Firmenich SA, Geneva, Switzerland), 3-methyl-(4 / 5)-cyclopentadecenone, (supplier: Firmenich SA, Geneva, Switzerland), 3-methylcyclopentadecanone (supplier: Firmenich SA, Geneva, Switzerland), pentadecanolide (supplier: Firmenich SA, Geneva, Switzerland), cyclopentadecanone (supplier: Firmenich SA, Geneva, Switzerland), (1-ethoxyethoxy)cyclododecane (Supplier: Firmenich SA, Geneva, Switzerland), 1,4-dioxacycloheptadecane-5,17-dione, 4,8-cyclododecadien-1-one; - Group 7: (+-)-2-Methyl-3-[4-(2-methyl-2-propanyl)phenyl]propanal (Supplier: Givaudan SA, Vernier, Switzerland), 2,2,2-trichloro-1-phenylethyl acetate.

[0048] Preferably, the perfume comprises at least 30%, preferably at least 50%, more preferably at least 60% of ingredients selected from groups 1 to 7 as defined above. More preferably, said perfume comprises at least 30%, preferably at least 50% of ingredients from groups 3 to 7 as defined above. Most preferably, said perfume comprises at least 30%, preferably at least 50% of ingredients from groups 3, 4, 6 or 7 as defined above.

[0049] According to another preferred embodiment, the perfume comprises at least 30%, preferably at least 50%, more preferably at least 60% of ingredients having a logP greater than 3, preferably greater than 3.5, even more preferably greater than 3.75.

[0050] According to a particular embodiment, the perfume used in the present invention contains less than 10% by weight of primary alcohols, less than 15% by weight of secondary alcohols, and less than 20% by weight of tertiary alcohols. Advantageously, the perfume used in the present invention does not contain any primary alcohols and contains less than 15% of secondary and tertiary alcohols.

[0051] According to one embodiment, the oil phase (or oily core) comprises: - 25-100% by weight of perfume oil containing at least 15% by weight of high impact perfume raw materials with a LogT of less than -4, and - 1.07g / cm 3 Density adjusting material with super high density 0-75% by weight Includes.

[0052] A "high impact perfume raw material" is to be understood as a perfume raw material having a LogT of less than -4. The odor threshold concentration of a chemical compound is determined in part by its shape, polarity, partial charge and molecular mass. For convenience, the odor threshold concentration is expressed as the base 10 logarithm of the threshold concentration, i.e., Log[Threshold] ("LogT").

[0053] The density adjustment material is 1.07 g / cm 3 By this is meant a material which has a density of 0.1 to 100% and which is preferably low-odor or odorless.

[0054] The odor threshold concentration of the fragrance compound is determined using a gas chromatograph ("GC"). Specifically, the gas chromatograph is calibrated with the exact amount of fragrance oil component injected by syringe, the exact split ratio, and hydrocarbon standards of known concentration and chain length distribution to determine the hydrocarbon response. The air flow rate is precisely measured and the sampling volume is calculated, assuming a human inhalation time lasts 12 seconds. Since the exact concentration at the detector at any time is known, the mass per inhalation volume and therefore the concentration of the fragrance compound is known. To determine the threshold concentration, a solution of the back-calculated concentration is sent to a sniff port. Panelists sniff the GC eluate and identify the retention time when they notice an odor. The average of all panelists determines the odor threshold concentration of the fragrance compound. Determination of odor thresholds is described in more detail in C. Vuilleumier et al., Multidimensional Visualization of Physical and Perceptual Data Leading to a Creative Approach in Fragrance Development, Perfume & Flavorist, Vol. 33, September,, 2008, pages 54-61.

[0055] High impact fragrance ingredients with LogT less than -4 and 1.07 g / cm 3The properties of density adjusting materials having a density of greater than 1000 nm are described in WO2018115250, the contents of which are incorporated by reference.

[0056] According to one embodiment, the high impact perfume raw materials having a LogT of less than -4 are (+-)-1-methoxy-3-hexanethiol, 4-(4-hydroxy-1-phenyl)-2-butanone, 2-methoxy-4-(1-propenyl)-1-phenylacetate, pyrazobutyle, 3-propylphenol, 1-(3-methyl-1-benzofuran-2-yl)ethanone, 2-(3-phenylpropyl)pyridine, 1-(3,3 / 5,5-dimethyl-1-cyclohexen-1-yl)- 4-Penten-1-one, 1-(5,5-dimethyl-1-cyclohexen-1-yl)-4-penten-1-one, (3RS,3aRS,6SR,7ASR)-perhydro-3,6-dimethyl-benzo[b]furan-2-one and a mixture containing (3SR,3aRS,6SR,7ASR)-perhydro-3,6-dimethyl-benzo[b]furan-2-one, (+-)-1-(5-ethyl-5-methyl-1-cyclohexen-1-yl)-4-penten-1-one, (1'S,3'R)-1-methyl-2-[ (1',2',2'-trimethylbicyclo[3.1.0]hex-3'-yl)methyl]cyclopropyl}methanol, (+-)-3-mercaptohexyl acetate, (2E)-1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one, H-methyl-2h-1,5-benzodioxepin-3(4H)-one, (2E,6Z)-2,6-nonadien-1-ol, (4Z)-4-dodecenal, (+-)-4-hydroxy-2,5-dimethyl-3(2H)-furanium Mixture containing non, methyl 2,4-dihydroxy-3,6-dimethylbenzoate, 3-methylindole, (+-)-perhydro-4α,8aβ-dimethyl-4a-naphthalenol, patchoulol, 2-methoxy-4-(1-propenyl)phenol, (+-)-5,6-dihydro-4-methyl-2-phenyl-2H-pyran and tetrahydro-4-methylene-2-phenyl-2H-pyran, 4-methylene-2-phenyltetrahydro-2H-pyran and (+-)-4-methyl-2-phenyl-3,Mixture containing 6-dihydro-2H-pyran, 4-hydroxy-3-methoxybenzaldehyde, nonylene aldehyde, 2-methoxy-4-propylphenol, 3-methyl-5-phenyl-2-pentenenitrile, 1-(spiro[4.5]dec-6 / 7-en-7-yl)-4-penten-1-one, 2-methoxynaphthalene, (-)-(3aR,5AS,9AS,9BR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan, 5-nonanolide, (3aR,5AS,9AS,9BR)-3a,6,6, 9a-Tetramethyldodecahydronaphtho[2,1-b]furan, 7-isopropyl-2H,4H-1,5-benzodioxepin-3-one, coumarin, 4-methylphenyl isobutyrate, (2E)-1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one, β,2,2,3-tetramethyl-δ-methylene-3-cyclopentene-1-butanol, δ-damascone ((2E)-1-[(1RS,2SR)-2,6,6-trimethyl-3-cyclohexen-1-yl]-2-buten-1-one), (+-)-3,6-dihydro-4,6-dimethyl-2-phenyl-2h-pyran, anisaldehyde, paracresol, 3-ethoxy-4-hydroxybenzaldehyde, methyl 2-aminobenzoate, ethyl methylphenylglycidate, octalactone gamma, ethyl 3-phenyl-2-propenoate, (-)-(2E)-2-ethyl-4-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-2-buten-1-ol, paracresyl acetate, dodecalactone, tricyclone, (+)-(3R,5Z)-3-methyl 1-5-cyclopentadecen-1-one, undecalactone, (1R,4R)-8-mercapto-3-p-menthanone, (3S,3AS,6R,7AR)-3,6-dimethylhexahydro-1-benzofuran-2(3H)-one, β-ionone, (+-)-6-pentyltetrahydro-2H-pyran-2-one, (3E,5Z)-1,3,5-undecatriene, 10-undecenal, (9E)-9-undecenal, (9Z)-9-undecenal, (Z)-4-decenal, (+-)-ethyl 2-methylpentanoate, 1,2-Diallyldisulfane, 2-Tridecenenitrile, 3-Tridecenenitrile, (+-)-2-Ethyl-4,4-dimethyl-1,3-oxathiane, (+)-(3R,5Z)-3-Methyl-5-cyclopentadecen-1-one, 3-(4-tert-butylphenyl)propanal, allyl(cyclohexyloxy)acetate, methyl naphthyl ketone, (+-)-(4E)-3-Methyl-4-cyclopentadecen-1-one, (+-)-5E3-Methyl-5-cyclopentadecen-1-one, cyclopropylmethyl 3-hexenoate, (4E )-4-Methyl-5-(4-methylphenyl)-4-pentenal, (+-)-1-(5-propyl-1,3-benzodioxol-2-yl)ethanone, 4-Methyl-2-pentylpyridine, (+-)-(E)-3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, (3aRS,5aSR,9aSR,9bRS)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan, (2S,5R)-5-Methyl-2-(2-propanyl)cyclohexanone oxime, 6-hexyl Tetrahydro-2H-pyran-2-one, (+-)-3-(3-isopropyl-1-phenyl)butanal, methyl 2-(3-oxo-2-pentylcyclopentyl)acetate, 1-(2,6,6-trimethyl-1-cyclohex-2-enyl)pent-1-en-3-one, indole, 7-propyl-2H,4H-1,5-benzodioxepin-3-one, ethyl praline, (4-methylphenoxy)acetaldehyde, ethyl tricyclo[5.2.1.0.2,6]decane-2-carboxylate, (+)-(1'S, 2S,E)-3,3-dimethyl-5-(2',2',3'-trimethyl-3'-cyclopenten-1'-yl)-4-penten-2-ol, (4E)-3,3-dimethyl-5-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-4-penten-2-ol, 8-isopropyl-6-methyl-bicyclo[2.2.2]oct-5-ene-2-carbaldehyde, methylnonylacetaldehyde, 4-formyl-2-methoxyphenyl 2-methylpropanoate, (E)-4-decenal, (+-)-2-ethyl-4-(2,2,3-Trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol, (1R,5R)-4,7,7-trimethyl-6-thiabicyclo[3.2.1]oct-3-ene, (1R,4R,5R)-4,7,7-trimethyl-6-thiabicyclo[3.2.1]octane, (-)-(3R)-3,7-dimethyl-1,6-octadien-3-ol, (E)-3-phenyl-2-propenenitrile, 4-methoxybenzyl acetate, (E) -3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol, allyl (2 / 3-methylbutoxy)acetate, (+-)-(2E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one, (1E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1-penten-3-one, and mixtures thereof.

[0057] According to one embodiment, the perfume raw materials having a LogT of less than -4 are selected in the group consisting of aldehydes, ketones, alcohols, phenols, esters, lactones, ethers, epoxides, nitriles and mixtures thereof.

[0058] According to one embodiment, the perfume raw material having a LogT less than -4 comprises at least one compound selected from the group consisting of alcohols, phenols, esters, lactones, ethers, epoxides, nitriles and mixtures thereof, preferably in an amount comprised between 20 and 70% by weight, based on the total weight of the perfume raw material having a LogT less than -4.

[0059] According to one embodiment, the perfume raw materials having a LogT less than -4 comprise 20-70% by weight of aldehydes, ketones and mixtures thereof based on the total weight of the perfume raw materials having a LogT less than -4.

[0060] Therefore, the remaining perfume raw materials contained in the oily core may have a LogT greater than -4.

[0061] According to one embodiment, the perfume raw materials having a LogT greater than -4 are ethyl 2-methylbutyrate, (E)-3-phenyl-2-propenyl acetate, (+-)-6 / 8-sec-butylquinoline, (+-)-3-(1,3-benzodioxol-5-yl)-2-methylpropanal, vergyl propionate, 1-(octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)-1-ethanone, methyl 2-((1RS,2RS)-3-oxo-2-pentylcyclopentyl)acetate, (+-)-(E)-4-methyl-3-decen-5-ol, 2,4-dimethyl-3-cyclohexene-1-carbaldehyde, 1,3,3-trimethyl-2-oxabicyclo[2.2.2]Octane, tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran, dodecanal, 1-oxa-12 / 13-cyclohexadecen-2-one, (+-)-3-(4-isopropylphenyl)-2-methylpropanal, aldehyde C11, (+-)-2,6-dimethyl-7-octen-2-ol, 3-cyclohexylpropanoic acid allyl, (Z)-3-hexenyl acetate, 5-methyl-2-(2-propanyl)cyclohexanone, heptanoic acid allyl, 2-(2-methyl-2-propanyl)cyclohexanone lopanyl)cyclohexyl acetate, 1,1-dimethyl-2-phenylethyl butyrate, geranyl acetate, neryl acetate, (+-)-1-phenylethyl acetate, 1,1-dimethyl-2-phenylethyl acetate, 3-methyl-2-butenyl acetate, ethyl 3-oxobutanoate, (2Z)-ethyl 3-hydroxy-2-butenoate, 8-p-menthanol, 8-p-menthanyl acetate, 1-p-menthanyl acetate, (+-)-2-(4-methyl-3-cyclohexen-1-yl)-2- Propanyl acetate, (+-)-2-methylbutyl butanoate, 2-{(1S)-1-[(1R)-3,3-dimethylcyclohexyl]ethoxy}-2-oxoethyl propionate, 3,5,6-trimethyl-3-cyclohexene-1-carbaldehyde, 2,4,6-trimethyl-3-cyclohexene-1-carbaldehyde, 2-cyclohexylethyl acetate, octanal, ethyl butanoate, (+-)-(3E)-4-(2,6,6-trimethyl-1 / 2-cyclohexen-1-yl)-3-butanoate Ten-2-one, 1-[(1RS,6SR)-2,2,6-trimethylcyclohexyl]-3-hexanol, 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane, 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane, ethyl hexanoate, undecanal, decanal, 2-phenylethyl acetate, (1S,2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol, (1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol), (+-)-3,7-dimethyl-3-octanol, 1-methyl-4-(2-propanylidene)cyclohexene, (+)-(R)-4-(2-methoxypropan-2-yl)-1-methylcyclohex-1-ene, vergyl acetate, (3R)-1-[(1R,6S)-2,2,6-trimethylcyclohexyl]-3-hexanol, (3S)-1 -[(1R,6S)-2,2,6-trimethylcyclohexyl]-3-hexanol, (3R)-1-[(1S,6S)-2,2,6-trimethylcyclohexyl]-3-hexanol, (+)-(1S,1'R)-2-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy]-2-methylpropylpropanoate, and mixtures thereof.

[0062] According to one embodiment, the core comprises a perfume formulation, the perfume formulation comprising: - 0 to 60% by weight of a hydrophobic solvent (based on the total weight of the fragrance formulation), - 40-100% by weight of perfume oil (based on the total weight of the perfume formulation) and the perfume oil has at least two, and preferably all, of the following properties: at least 35%, preferably at least 40%, preferably at least 50%, more preferably at least 60% of perfuming ingredients having a logP greater than 3, preferably greater than 3.5, at least 20%, preferably at least 25%, preferably at least 30%, more preferably at least 40% of bulky materials of groups 1 to 6, preferably 3 to 6, as defined herein, and at least 15%, preferably at least 20%, more preferably at least 25%, even more preferably at least 30% of high impact perfume materials having a LogT below -4, Optionally, a further hydrophobic active ingredient.

[0063] According to a particular embodiment, the perfume comprises 0-60% by weight of hydrophobic solvent.

[0064] According to a particular embodiment, the hydrophobic solvent is a density adjusting material, preferably selected in the group consisting of benzyl salicylate, benzyl benzoate, cyclohexyl salicylate, benzyl phenylacetate, phenylethyl phenylacetate, triacetin, ethyl citrate, methyl and ethyl salicylates, benzyl cinnamate, and mixtures thereof.

[0065] In certain embodiments, the hydrophobic solvent has a Hansen solubility parameter that matches the encapsulated perfume oil.

[0066] The term "Hansen Solubility Parameter" is understood to refer to the solubility parameter approach proposed by Charles Hansen, used to predict the solubility of polymers, developed on the basis that the total energy of vaporization of a liquid consists of several individual parts. To calculate the "weighted Hansen Solubility Parameter", it is necessary to combine the effects of (atomic) dispersion forces, (molecular) permanent dipole-dipole forces and (molecular) hydrogen bonding (electron exchange). The "weighted Hansen Solubility Parameter" is calculated by the weighting factor (δD 2 +δP 2 +δH 2 ) 0.5 where δD is the Hansen dispersion value (hereinafter also referred to as atomic dispersion force), δP is the Hansen polarizability value (hereinafter also referred to as dipole moment), and δH is the Hansen hydrogen bond ("h-bond") value (hereinafter also referred to as hydrogen bond). For a more detailed description of the parameters and values, see Charles Hansen, The Three Dimensional Solubility Parameter and Solvent Diffusion Coefficient, Danish Technical Press (Copenhagen, 1967).

[0067] The Euclidean difference in solubility parameters between the fragrance and the solvent is (4 × (δD 溶媒 -δD フレグランス ) 2 +(δP 溶媒 -δP フレグランス )2 +(δH 溶媒 -δH フレグランス ) 2 ) 0.5 where δDsolvent, δPsolvent and δHsolvent are the Hansen dispersion, Hansen polarizability and Hansen h-bonding values ​​of the solvent, respectively, and δDfragrance, δP フレグランス and δH フレグランス are the Hansen dispersion value, Hansen polarizability value and Hansen h-bonding value of the fragrance, respectively.

[0068] In certain embodiments, the perfume oil and the hydrophobic solvent have at least two Hansen solubility parameters selected from a first group consisting of an atomic dispersion force (δD) of 12-20, a dipole moment (δP) of 1-8, and a hydrogen bond (δH) of 2.5-11.

[0069] In certain embodiments, the perfume oil and the hydrophobic solvent have at least two Hansen solubility parameters selected from a second group consisting of an atomic dispersion force (δD) of 12 to 20, preferably 14 to 20, a dipole moment (δP) of 1 to 8, preferably 1 to 7, and a hydrogen bond (δH) of 2.5 to 11, preferably 4 to 11.

[0070] In certain embodiments, at least 90% of the perfume oils, preferably at least 95% of the perfume oils, and most preferably at least 98% of the perfume oils have at least two Hansen Solubility Parameters selected from a first group consisting of an atomic dispersion force (δD) of 12-20, a dipole moment (δP) of 1-8, and a hydrogen bond (δH) of 2.5-11.

[0071] In certain embodiments, the perfume oil and the hydrophobic solvent have at least two Hansen solubility parameters selected from a second group consisting of an atomic dispersion force (δD) of 12 to 20, preferably 14 to 20, a dipole moment (δP) of 1 to 8, preferably 1 to 7, and a hydrogen bond (δH) of 2.5 to 11, preferably 4 to 11.

[0072] According to one embodiment, the fragrance formulation comprises an odor modifier (which can be used in addition to the hydrophobic solvent, if one is present, or instead of the hydrophobic solvent, if one is not present).

[0073] Preferably, odor control agents are defined as odoriferous materials having: i. A vapor pressure of less than 0.0008 Torr at 22°C; ii. a clogP of 3.5 or greater, preferably 4.0 or greater, more preferably 4.5; iii. at least two Hansen solubility parameters selected from a first group consisting of atomic dispersion forces of 12-20, dipole moments of 1-7, and hydrogen bonds of 2.5-11; iv. at least two Hansen solubility parameters selected from a second group consisting of atomic dispersion forces of 14-20, dipole moments of 1-8, and hydrogen bonds of 4-11 in a solution with a compound having a vapor pressure range of 0.0008-0.08 Torr at 22 °C.

[0074] Preferably, the following ingredients can be mentioned as regulators by way of example, but the list is not limited to the following materials: alcohol C12, oxacyclohexadec-12 / 13-en-2-one, 3-[(2',2',3'-trimethyl-3'-cyclopenten-1'-yl)methoxy]-2-butanol, cyclohexadecanone, (Z)-4-cyclopentadecen-1-one, cyclopentadecanone, (8Z)-oxacycloheptadeca-8-en-2-one, 2-[5-(tetrahydro-5-methyl-5-vinyl-2-furyl)-tetrahydro-5-methyl-2-furyl]-2-propanol, muguetaldehyde (muguet aldehyde), 1,5,8-trimethyl-13-oxabicyclo[10.1.0]trideca-4,8-diene, (+-)-4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene, (+)-(1S,2S,3S,5R)-2,6,6-trimethylspiro[bicyclo[3.1.1]heptane-3,1'-cyclohexane]-2'-en-4'-one, oxacyclohexadecan-2-one, 2-{(1S)-1-[(1R)-3, 3-Dimethylcyclohexyl]ethoxy}-2-oxoethylpropionate, (+)-(4R,4aS,6R)-4,4a-dimethyl-6-(1-propen-2-yl)-4,4a,5,6,7,8-hexahydro-2(3H)-naphthalenone, amylcinnamaldehyde, hexylcinnamaldehyde, hexyl salicylate, (1E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,6-heptadiene-3-one, (9Z)-9-cycloheptadecen-1-one.

[0075] According to a particular embodiment, the hydrophobic material does not include any active ingredients (such as fragrances). According to this particular embodiment, the hydrophobic material comprises, preferably consists of, a hydrophobic solvent, preferably isopropyl myristate, triglycerides (e.g. Neobee® MCT oil, vegetable oils), D-limonene, silicone oils, mineral oils and mixtures thereof, and optionally a hydrophilic solvent, preferably selected in the group consisting of 1,4-butanediol, benzyl alcohol, triethyl citrate, triacetin, benzyl acetate, ethyl acetate, propylene glycol (1,2-propanediol), 1,3-propanediol, dipropylene glycol, glycerol, glycol ethers and mixtures thereof.

[0076] The term "biocide" refers to a chemical that can kill or reduce or prevent the growth and / or accumulation of living organisms (e.g., microorganisms). Biocides are commonly used in the medical, agricultural, forestry, and forestry industries to prevent fouling of, for example, water, agricultural products including seeds, and oil pipelines. Biocides can be pesticides, including fungicides, herbicides, insecticides, algaecides, molluscicides, acaricides, and rodenticides, and / or antimicrobials, such as bactericides, antibiotics, antibacterial agents, antivirals, antifungals, antiprotozoals, and / or antiparasitics.

[0077] As used herein, "pesticide" refers to a substance that acts to repel or attract pests, reduce, inhibit or promote their growth, development or activity. A pest refers to any organism, whether animal, plant or fungus, that invades or is a nuisance to plants or animals, and includes insects, particularly arthropods, mites, spiders, fungi, weeds, bacteria and other microorganisms.

[0078] By "flavor oil" is meant herein a flavoring ingredient or a mixture of flavoring ingredients, solvents or auxiliaries currently used for the preparation of flavoring formulations, i.e. a specific mixture of ingredients intended to be added to an edible composition or chewable product to impart, improve or modify its organoleptic properties, in particular its flavor and / or taste. Flavoring ingredients are well known to those skilled in the art, their nature does not require a detailed description here, which is in any case not comprehensive, and the skilled flavorist can select them on the basis of general knowledge, depending on the intended use or application, and the organoleptic effect that it is desired to achieve. Many of these flavoring ingredients are described in references, for example in the book Perfume and Flavor Chemicals, 1969, Montclair, NJ, USA, by S. Arctander, or its more recent editions, or other treatises of the same kind, for example Fenaroli's Handbook of Flavor Ingredients, 1975, CRC Press, or Synthetic Food Adjuncts, 1947, by MB Jacobs, van Nostrand Co., Inc. Solvents and adjuvants currently used for the preparation of flavoring formulations are also well known in the art.

[0079] In a particular embodiment, the flavor is a mint flavor, hi a more particular embodiment, the mint is selected from the group consisting of peppermint and spearmint.

[0080] In a further embodiment, the flavoring is a cooling agent or mixtures thereof.

[0081] In another embodiment, the flavor is a menthol flavor.

[0082] Flavors derived from or based on fruits in which citric acid is the predominant natural acid include, but are not limited to, citrus fruits (e.g., lemon, lime), limonene, strawberry, orange, and pineapple. In one embodiment, the flavored food product is lemon, lime, or orange juice extracted directly from the fruit. Further embodiments of the flavor include juices or liquids extracted from orange, lemon, grapefruit, key lime, citron, clementine, mandarin, tangerine, and any other citrus fruit, or any variety or hybrid thereof. In a particular embodiment, the flavor includes liquids extracted or distilled from orange, lemon, grapefruit, key lime, citron, clementine, mandarin, tangerine, any other citrus fruit, or any variety or hybrid thereof, pomegranate, kiwi fruit, watermelon, apple, banana, blueberry, melon, ginger, bell pepper, cucumber, passion fruit, mango, pear, tomato, and strawberry.

[0083] In certain embodiments, the flavor comprises a composition comprising limonene, and in certain embodiments, the composition is a citrus that further comprises limonene.

[0084] In another particular embodiment, the flavor comprises a flavor selected from the group including strawberry, orange, lime, tropical, berry mix, and pineapple.

[0085] The expression flavour not only includes flavours that impart or modify the smell of a food product, but also ingredients that impart or modify tastes, which do not necessarily have a taste or smell of their own, but can modify the tastes imparted by other ingredients, for example ingredients that enhance saltiness, enhance sweetness, enhance umami, reduce bitterness, etc.

[0086] In further embodiments, a suitable sweetening component can be included in the particles described herein. In certain embodiments, the sweetening component is selected from the group consisting of sugar (such as, but not limited to, sucrose), stevia components (such as, but not limited to, stevioside or rebaudioside A), sodium cyclamate, aspartame, sucralose, sodium saccharin, and acesulfame K, or mixtures thereof.

[0087] Polymer Shell According to one embodiment, the polymer shell comprises a material selected from the group consisting of polyamides, polyureas, polyurethanes, polyesters, polyacrylates, polysiloxanes, polycarbonates, polysulfonamides, polymers of urea and formaldehyde, melamine and formaldehyde, melamine and urea or melamine and glyoxal, and mixtures thereof.

[0088] According to a particular embodiment, the polymeric material is a polyamide.

[0089] According to a particular embodiment, the polyamide material is obtained from the reaction of an acyl chloride with at least one amino compound (ie at least one amino compound A), such as ethylenediamine (EDA).

[0090] According to a particular embodiment, the polyamide material is obtained from the reaction of an acyl chloride with at least two amino compounds (i.e., at least one amino compound A and at least one amino compound B), such as L-lysine and ethylenediamine (EDA).

[0091] According to a particular embodiment, the polyamide is obtained from the reaction of an acyl chloride with at least three amino compounds (i.e. at least one amino compound A, at least one amino compound B and at least one amino compound C), such as L-lysine, ethylenediamine (EDA) and diethylenetriamine (DETA).

[0092] The amino compounds (A and / or B and / or C) were selected from the group consisting of cystamine, cystamine hydrochloride, cystine, cystine hydrochloride, cystine dialkyl esters, cystine dialkyl ester hydrochlorides, xylylenediamine, 1,2-diaminocyclohexane, 1,4-diaminocyclohexane, polyetheramines, ethylenediamine, diethylenetriamine, spermine, spermidine, polyamidoamine (PAMAM), guanidine carbonate, chitosan, tris-(2-aminoethyl)amine, 3-aminopropyltriethoxysilane, 1,4-diaminobutane, 2,2-dimethyl-1,3-propanediamine, 1,3-diaminopentane (Dytek EP diamine), 1,2-diaminopropane, triethylenetetramine, 1,3-diaminopropane; urea; ethyleneurea; aminoguanidine bicarbonate; 1-(2-aminoethyl)imidazolidin-2-one; N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine; N1-(2-aminoethyl)-N1-dodecyl-1,2-ethanediamine; aminoethylethanolamine; N1-(3-aminopropyl)propane-1,3-diamine, polyethyleneimine, amino acids such as L-lysine, L-arginine, L-histidine, L-tryptophan, L-serine, L-glutamine, L-threonine, L-leucine and / or their derived oligomers and polymers and mixtures thereof.

[0093] According to a particular embodiment, at least one of the amino compounds is an amino acid, preferably selected in the group consisting of L-lysine, L-arginine, L-histidine, L-tryptophan, L-serine, L-glutamine, L-threonine, L-leucine and mixtures thereof.

[0094] According to one embodiment, the amino compounds (A and / or B and / or C) are selected in the group consisting of xylylenediamine, 1,2-diaminocyclohexane, 1,4-diaminocyclohexane, L-lysine, L-lysine ethyl ester, polyetheramines (Jeffamine®), ethylenediamine, diethylenetriamine, spermine, spermidine, polyamidoamines (PAMAM), guanidine carbonate, chitosan, tris-(2-aminoethyl)amine, 3-aminopropyltriethoxysilane, L-arginine, 1,4-diaminobutane, 2,2-dimethyl-1,3-propanediamine, 1,3-diaminopentane (Dytek EP Diamine), 1,2-diaminopropane, triethylenetetramine, amines with disulfide bonds, such as cystamine, cystamine hydrochloride, cystine, cystine hydrochloride, cystine dialkyl esters, cystine dialkyl ester hydrochlorides, and mixtures thereof.

[0095] According to a particular embodiment, the acyl chloride has the following formula (I): [ka] [In the formula, n is an integer varying from 1 to 8, preferably from 1 to 6, more preferably from 1 to 4; X is (i) to (xi), and more particularly (i) to (vi). [ka] (n+1)-valent C2 to C optionally containing at least one group selected from 45 is a hydrocarbon group, R is a hydrogen atom or an alkyl group such as a methyl or ethyl group, preferably a hydrogen atom. has.

[0096] "...hydrocarbon group..." is understood to mean that said group consists of hydrogen and carbon atoms and may be in the form of an aliphatic hydrocarbon, i.e. linear or branched saturated hydrocarbon (e.g. alkyl group), linear or branched unsaturated hydrocarbon (e.g. alkenyl or alkynyl group), saturated cyclic hydrocarbon (e.g. cycloalkyl) or unsaturated cyclic hydrocarbon (e.g. cycloalkenyl or cycloalkynyl), or aromatic hydrocarbon, i.e. aryl group, or may be in the form of a mixture of the above types of groups, for example, a particular group may contain linear alkyl, branched alkenyl (e.g. having one or more carbon-carbon double bonds), (poly)cycloalkyl and aryl moieties, unless a specific limitation to only one type is mentioned. Similarly, in all embodiments of the present invention, when a group is referred to as being in the form of more than one type of topology (e.g. linear, cyclic or branched) and / or saturated or unsaturated (e.g. alkyl, aromatic or alkenyl), it is also meant that the group may have any one of the above topologies or contain moieties that are saturated or unsaturated, as explained above. Similarly, in all embodiments of the present invention, when a group is referred to as being in one type of saturated or unsaturated (e.g., alkyl) form, it is meant that said group may be of any type of topology (e.g., linear, cyclic or branched) or may have some moieties with different topologies.

[0097] The term "hydrocarbon radical optionally containing ..." is understood to mean that said hydrocarbon radical optionally contains heteroatoms, forming ether, thioether, amine, nitrile or carboxylic acid groups and derivatives including, for example, esters, acids, amides. These groups may be attached laterally to said hydrocarbon radical by replacing a hydrogen atom of the hydrocarbon radical, or may be inserted into a hydrocarbon chain or ring by replacing a carbon atom of the hydrocarbon radical (if chemically possible).

[0098] According to a particular embodiment, the acyl chloride is selected from the group consisting of benzene-1,3,5-tricarbonyl trichloride (trimesoyl trichloride), benzene-1,2,4-tricarbonyl trichloride, benzene-1,2,4,5-tetracarbonyl tetrachloride, cyclohexane-1,3,5-tricarbonyl trichloride, isophthaloyl dichloride, diglycolyl dichloride, terephthaloyl chloride, fumaryl dichloride, adipoyl chloride, succinic acid dichloride, propane-1, 2,3-Tricarbonyl trichloride, cyclohexane-1,2,4,5-tetracarbonyl tetrachloride, 2,2'-disulfanediyldisuccinyl dichloride, 2-(2-chloro-2-oxo-ethyl)sulfanylbutanedioyl dichloride, (4-chloro-4-oxobutanoyl)-L-glutamoyl dichloride, (S)-4-((1,5-dichloro-1,5-dioxopentan-2-yl)amino)-4-oxobutanoic acid, 2,2-bis[(4-chloro-4-oxo 2-[2,2-bis[(4-chloro-4-oxo-butanoyl)oxymethyl]butoxymethyl]-2-[(4-chloro-4-oxo-butanoyl)oxymethyl]butyl]4-chloro-4-oxo-butanoate, 2,2-bis[(2-chlorocarbonylbenzoyl)oxymethyl]butyl 2-chlorocarbonyl-benzoate, [2-[2,2-bis[(2-chlorocarbonylbenzoyl)oxymethyl]butyl

[0036] The aryl ester is selected from the group consisting of 4-(2,4,5-trichlorocarbonylbenzoyl)oxybutyl 2,4,5-trichlorocarbonyl-benzoate, 4-(2,4,5-trichlorocarbonylbenzoyl)oxybutyl 2,4,5-trichlorocarbonyl-benzoate, propane-1,2,3-triyltris(4-chloro-4-oxobutanoate), propane-1,2-diylbis(4-chloro-4-oxobutanoate) and mixtures thereof.

[0099] According to a particular embodiment, the acyl chloride is selected from the group consisting of benzene-1,2,4-tricarbonyl trichloride, benzene-1,2,4,5-tetracarbonyl tetrachloride, cyclohexane-1,3,5-tricarbonyl trichloride, isophthaloyl dichloride, diglycolyl dichloride, terephthaloyl chloride, fumaryl dichloride, adipoyl dichloride, succinic acid dichloride, propane-1,2,3-tricarbonyl trichloride, cyclohexane-1, 2,4,5-Tetracarbonyltetrachloride, 2,2'-disulfanediyldisuccinyl dichloride, 2-(2-chloro-2-oxo-ethyl)sulfanylbutanedioyl dichloride, (4-chloro-4-oxobutanoyl)-L-glutamoyl dichloride, (S)-4-((1,5-dichloro-1,5-dioxopentan-2-yl)amino)-4-oxobutanoic acid, 2,2-bis[(4-chloro-4-oxo-butanoyl)oxymethyl]butyl 4-Chloro-4-oxo-butanoate, [2-[2,2-bis[(4-chloro-4-oxo-butanoyl)oxymethyl]butoxymethyl]-2-[(4-chloro-4-oxo-butanoyl)oxymethyl]butyl] 4-chloro-4-oxo-butanoate, 2,2-bis[(2-chlorocarbonylbenzoyl)oxymethyl]butyl 2-chlorocarbonyl-benzoate, [2-[2,2-bis[(2-chlorocarbonylbenzoyl)oxymethyl] butoxymethyl]-2-[(2-chlorocarbonylbenzoyl)oxymethyl]butyl] 2-chlorocarbonylbenzoate, 4-(2,4,5-trichlorocarbonylbenzoyl)oxybutyl 2,4,5-trichlorocarbonyl-benzoate, propane-1,2,3-triyltris(4-chloro-4-oxobutanoate), propane-1,2-diylbis(4-chloro-4-oxobutanoate) and mixtures thereof.

[0100] According to another particular embodiment, the acyl chloride is selected from the group consisting of fumaryl dichloride, adipoyl dichloride, succinic acid dichloride, propane-1,2,3-triyltris(4-chloro-4-oxobutanoate), propane-1,2-diylbis(4-chloro-4-oxobutanoate) and mixtures thereof.

[0101] According to one embodiment, the acyl chloride is a mixture of acyl chlorides.

[0102] The weight ratio between the acyl chloride and the hydrophobic material is preferably comprised between 0.01 and 0.09, more preferably between 0.02 and 0.07.

[0103] According to a particular embodiment, the acyl chloride is used in an amount comprised between 1.7 and 7% by weight, preferably between 2.5 and 5% by weight, based on the total weight of the hydrophobic material.

[0104] According to a particular embodiment, the protein is selected in the group consisting of potato protein, chickpea protein, pea protein and mixtures thereof.

[0105] According to a particular embodiment, the core-shell microcapsules are a core comprising a hydrophobic material, preferably a perfume oil; a polyamide shell comprising the reaction product of one acyl chloride with at least two amino compounds, preferably L-lysine and ethylenediamine, the polyamide shell comprising potato protein; and Includes.

[0106] According to a particular embodiment, the core-shell microcapsules are a core comprising a hydrophobic material, preferably a perfume oil; a polyamide shell comprising a reaction product of one acyl chloride with at least two amino compounds, preferably L-lysine and ethylenediamine, the polyamide shell comprising chickpea protein; and Includes.

[0107] According to a particular embodiment, the core-shell microcapsules are a core comprising a hydrophobic material, preferably a perfume oil; a polyamide shell comprising the reaction product of one acyl chloride with at least two amino compounds, preferably L-lysine and ethylenediamine, the polyamide shell comprising pea protein; and Includes.

[0108] The polyamide shell may comprise the reaction product of an acyl chloride with at least three amino compounds, preferably L-lysine, ethylenediamine and ethylenetriamine.

[0109] Another subject of the present invention is a composition comprising at least one microcapsule, the microcapsule comprising: a core comprising a hydrophobic material, preferably a fragrance; - Polyamide-based shells, based on the total weight of the shell Acyl chloride in an amount of 5 to 98%, preferably 20 to 98%, more preferably 30 to 85% w / w, an amino compound A in an amount between 1% and 50% w / w, preferably between 7% and 40% w / w; optionally an amino compound B in an amount comprised between 1% and 50% w / w, preferably between 2 and 25% w / w, optionally an amino compound C in an amount comprised between 1% and 50% w / w, preferably between 2 and 25% w / w, a protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, broad bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof, in an amount comprised between 0.1 and 90% w / w, preferably between 0.1 and 75% w / w, more preferably between 1 and 70% w / w; The shell and The polyamide-based core-shell microcapsule or polyamide-based core-shell microcapsule slurry comprises:

[0110] According to another embodiment, the polyamide-based shell comprises, based on the total weight of the shell, Acyl chloride in an amount of 5 to 98%, preferably 5 to 40%, more preferably 5 to 30% w / w, an amino compound A in an amount between 1% and 50% w / w, preferably between 7% and 40% w / w; optionally an amino compound B in an amount comprised between 1% and 50% w / w, preferably between 2 and 25% w / w, optionally an amino compound C in an amount comprised between 1% and 50% w / w, preferably between 2 and 25% w / w, a protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, broad bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof, in an amount comprised between 0.1 and 90% w / w, preferably between 0.1 and 75% w / w, more preferably between 1 and 70% w / w; This includes reaction products of:

[0111] According to one embodiment, the shell comprises an amount of protein comprised between 1 and 80% w / w, more preferably between 10 and 75% w / w, even more preferably between 30 and 70% w / w, based on the total weight of the shell.

[0112] In certain embodiments, the shell material is a biodegradable material.

[0113] In certain embodiments, the shell is at least 40%, preferably at least 45%, 50%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 98% biodegradable within 60 days according to OECD 301F.

[0114] In certain embodiments, the core-shell microcapsules are at least 40%, preferably at least 60%, preferably at least 65%, 70%, 75%, 80%, 85%, 90%, 95% or 98% biodegradable within 60 days according to OECD 301F.

[0115] Thereby it is understood that the core-shell microcapsules, including all components such as the core, shell and optionally coating, may have a biodegradability of at least 40%, preferably at least 60%, preferably at least 65%, 70%, 75%, 80%, 85%, 90%, 95% or 98% within 60 days according to OECD 301F.

[0116] In certain embodiments, the oil core, preferably the perfume oil, has a biodegradability of at least 40%, preferably at least 60%, preferably at least 65%, 70%, 75%, 80%, 85%, 90%, 95% or 98% within 60 days according to OECD 301F.

[0117] OECD301F is a standard test method for biodegradability established by the Organization for Economic Cooperation and Development.

[0118] Exemplary methods for extraction of shells for the determination of biodegradability are disclosed in Gasparini and all in Molecules 2020, 25,718.

[0119] In certain embodiments, the microcapsules have a stability or chemical stability of 50% or less, preferably 40% or less, preferably 35% or less, preferably 30% or less. Typically, the stability or chemical stability of the microcapsules is determined as 50% or less, preferably 40% or less, preferably 35% or less, preferably 30% or less of the perfume leaking out of the microcapsules when incorporated into a consumer product at a particular storage time and temperature, and the microcapsules are preferably stable in a fabric softener, liquid detergent, body wash, deodorant or antiperspirant after storage at 37°C for 15 days, more preferably 30 days at 37°C, and are stable in a body lotion, shampoo or hair conditioner after storage at 40°C for at least 2 weeks.

[0120] Furthermore, the microcapsules preferably exhibit a detectable frictional effect in fresh samples, and preferably exhibit a detectable frictional effect after storage at 37°C for 15 days, and even more preferably after storage at 37°C for 30 days.

[0121] protein The protein used in the present invention is a vegetable protein or a vegetable-derived protein. "Vegetable protein" or "vegetable-derived protein" are used interchangeably in the present invention. The protein is selected in the group consisting of potato protein, chickpea protein, pea protein, algae protein, broad bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof.

[0122] The potato protein is typically extracted from potato tubers (Solanum tuberosum). According to one embodiment, the potato protein is a native potato protein and preferably comprises or consists of patatin.

[0123] According to one embodiment, the solubility of the protein, preferably potato protein, is greater than 10%. According to one embodiment, the solubility of the protein, preferably potato protein, is greater than 20%. According to one embodiment, the solubility of the protein, preferably potato protein, is greater than 30%. According to one embodiment, the solubility of the protein, preferably potato protein, is greater than 40%. According to one embodiment, the solubility of the protein, preferably potato protein, is greater than 50%. According to one embodiment, the solubility of the protein, preferably potato protein, is greater than 60%. According to one embodiment, the solubility of the protein, preferably potato protein, is greater than 70%. According to one embodiment, the solubility of the protein, preferably potato protein, is greater than 80%. According to one embodiment, the solubility of the protein, preferably potato protein, is greater than 90%. The above solubilities are in water at room temperature (typically 20° C.), preferably at native pH.

[0124] The protein used in the present invention may be native or may be partially or completely denatured by any suitable method. Denaturation is the process of changing the conformational structure of a protein by unfolding, i.e., involving the destruction, and possibly degradation, of both the secondary and tertiary structure of the protein. In fact, denaturation implies that many of the weak links or bonds (e.g. hydrogen bonds) within the protein molecule that are responsible for the highly ordered structure of the protein in the native state are broken. Denaturation can be reversible (protein can return to native state when the effect of denaturation is removed) or irreversible.

[0125] Denaturation can be achieved in a variety of ways. Proteins can be denatured by temperature, radiation, or mechanical stress, including shear, by changes in pH (treatment with base or acid), by treatment with oxidizing or reducing agents, by inorganic salts, by certain organic solvents, by chaotropic agents (i.e., those with a positive chaotropic value (kJ Kg on the Holdsworth scale)). -1The molecule can be denatured by exposure to a compound having a molecular weight of 1000 to 15000, such as a guanidine salt, e.g., guanidine carbonate, guanidine hydrochloride, urea, calcium chloride, n-butanol, ethanol, lithium perchlorate, lithium acetate, magnesium chloride, phenol, 2-propanol, sodium dodecyl sulfate, thiourea.

[0126] Proteins used in the present invention can also be derivatized or modified (e.g., derivatized or chemically modified). For example, proteins can be modified by the covalent attachment of sugars, lipids, peptides, or chemical groups such as phosphate or methyl.

[0127] According to one embodiment, the protein may be treated prior to use by heat treatment (typically at about 90° C.) in the presence or absence of salt (e.g., CaCl 2 or NaCl).

[0128] Outer Coating According to certain embodiments of the invention, the microcapsules comprise an outer coating, the outer coating comprising a coating material selected from the group consisting of non-ionic polysaccharides, cationic polymers, polysuccinimide derivatives (e.g., as described in WO2021185724) and mixtures thereof, thereby forming an outer coating on the microcapsules.

[0129] Nonionic polysaccharide polymers are well known to those skilled in the art and are described, for example, in WO 2012 / 007438, page 29, lines 1-25, and in WO 2013 / 026657, page 2, lines 12-19, and page 4, lines 3-12. Preferred nonionic polysaccharides are selected from the group consisting of locust bean gum, xyloglucan, guar gum, hydroxypropyl guar, hydroxypropyl cellulose and hydroxypropyl methylcellulose.

[0130] Cationic polymers are well known to those skilled in the art. Preferred cationic polymers have a cationic charge density of at least 0.5 meq / g, more preferably at least about 1.5 meq / g, even more preferably less than about 7 meq / g, more preferably less than about 6.2 meq / g. The cationic charge density of the cationic polymer can be determined by the Kjeldahl method described in the United States Pharmacopoeia Chemical Test for Nitrogen Determination. Preferred cationic polymers are selected from those having units containing primary, secondary, tertiary and / or quaternary amine groups which may form part of the main polymer chain or may be carried on side chain substituents directly attached thereto. The weight average (Mw) molecular weight of the cationic polymer is preferably 10,000 to 3.5 M Daltons, more preferably 50,000 to 1.5 M Daltons. According to particular embodiments, cationic polymers based on acrylamide, methacrylamide, N-vinylpyrrolidone, quaternized N,N-dimethylamino methacrylate, diallyldimethylammonium chloride, quaternized vinylimidazole (3-methyl-1-vinyl-1H-imidazol-3-ium chloride), vinylpyrrolidone, acrylamidopropyltrimonium chloride, cassia hydroxypropyltrimonium chloride, guar hydroxypropyltrimonium chloride or polygalactomannan 2-hydroxypropyltrimethylammonium chloride ether, starch hydroxypropyltrimonium chloride and cellulose hydroxypropyltrimonium chloride are used. Preferably, the copolymer is selected from the group consisting of polyquaternium-5, polyquaternium-6, polyquaternium-7, polyquaternium-10, polyquaternium-11, polyquaternium-16, polyquaternium-22, polyquaternium-28, polyquaternium-43, polyquaternium-44, polyquaternium-46, cassia hydroxypropyltrimonium chloride, guar hydroxypropyltrimonium chloride or polygalactomannan 2-hydroxypropyltrimethylammonium chloride ether, starch hydroxypropyltrimonium chloride and cellulose hydroxypropyltrimonium chloride.Specific examples of commercially available products include Salcare® SC60 (cationic copolymer of acrylamidopropyltrimonium chloride and acrylamide, supplier: BASF) or Luviquat®, such as PQ 11N, FC 550 or Style (polyquaternium-11-68 or quaternized copolymer of vinylpyrrolidone, supplier: BASF), or Jaguar® (C13S or C17, supplier: Rhodia).

[0131] According to any one of the above embodiments of the present invention, said polymer is added in an amount comprised between about 0% and 5% (w / w), or even between about 0.1% and 2% (w / w), the percentage being expressed on a w / w basis with respect to the total weight of the slurry. It is clearly understood by those skilled in the art that only a portion of said added polymer is incorporated / attached to the microcapsule shell.

[0132] According to a particular embodiment, the microcapsules of the invention comprise a mineral layer, preferably comprising a material selected from the group consisting of iron oxide, iron oxyhydroxide, titanium oxide, zinc oxide, calcium carbonate, calcium phosphate, barium salts, strontium salts, magnesium salts and mixtures thereof.

[0133] Optional Ingredients When the microcapsules are in the form of a slurry, the microcapsule slurry may contain auxiliary ingredients selected from the group of thickeners / rheology modifiers, antimicrobial agents, opacity enhancers, mica particles, salts, pH stabilizers / buffering ingredients, preferably in an amount comprised between 0 and 15% by weight based on the total weight of the slurry.

[0134] According to another embodiment, the microcapsule slurry of the present invention comprises additional non-encapsulated (ie, non-encapsulated) flavoring, preferably in an amount comprised between 5 and 50% by weight based on the total weight of the slurry.

[0135] solid particles Another subject of the present invention is - a carrier material, preferably a polymeric carrier material selected from the group consisting of polyvinyl acetate, polyvinyl alcohol, dextrin, natural or modified starch, vegetable gum, pectin, xanthan, alginate, carrageenan, cellulose derivatives and mixtures thereof, - microcapsules as defined above encapsulated in said carrier material; - optionally with non-encapsulated flavorings encapsulated in said carrier material; are solid particles comprising:

[0136] The solid particles and microcapsule powders defined above can be used interchangeably in the present invention.

[0137] Method for preparing a microcapsule slurry Another object of the present invention is a method for preparing a core-shell microcapsule slurry, comprising the steps of: a) preparing an oil phase comprising a hydrophobic material, preferably a fragrance, to form an oil phase; b) dispersing the oil phase obtained in step a) in an aqueous phase to form an oil-in-water emulsion; c) carrying out a curing step to form microcapsules in the form of a slurry. Including, A multifunctional monomer is added to the oil phase and / or the water phase; A protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, faba bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof is added to the oil phase and / or the water phase.

[0138] According to one embodiment, the multifunctional monomer is selected in the group consisting of at least one acyl chloride, polyisocyanate, polyanhydride (eg, polymaleic anhydride), polyepoxide, acrylate monomer, polyalkoxysilane, and mixtures thereof.

[0139] According to a particular embodiment, the multifunctional monomer is a polyisocyanate having at least two isocyanate functional groups.

[0140] Suitable polyisocyanates for use according to the present invention include aromatic polyisocyanates, aliphatic polyisocyanates and mixtures thereof. The polyisocyanates contain at least two, preferably at least three, isocyanate functional groups, but may contain up to six, or even only four, isocyanate functional groups. According to a particular embodiment, triisocyanates (three isocyanate functional groups) are used.

[0141] According to one embodiment, the polyisocyanate is an aromatic polyisocyanate.

[0142] The term "aromatic polyisocyanate" is intended to encompass any polyisocyanate containing an aromatic moiety. Preferably, the aromatic polyisocyanate contains a phenyl, toluyl, xylyl, naphthyl or diphenyl moiety, more preferably a toluyl or xylyl moiety. Preferred aromatic polyisocyanates include biurets, polyisocyanurates and trimethylolpropane adducts of diisocyanates, more preferably one of the specific aromatic moieties listed above. More preferably, the aromatic polyisocyanate is a polyisocyanurate of toluene diisocyanate (available under the trade name Desmodur® RC from Bayer), a trimethylolpropane adduct of toluene diisocyanate (available under the trade name Desmodur® L75 from Bayer), a trimethylolpropane adduct of xylylene diisocyanate (available under the trade name Takenate® D-110N from Mitsui Chemicals, Inc.). In a most preferred embodiment, the aromatic polyisocyanate is a trimethylolpropane adduct of xylylene diisocyanate.

[0143] According to another embodiment, the polyisocyanate is an aliphatic polyisocyanate. The term "aliphatic polyisocyanate" is defined as a polyisocyanate that does not contain any aromatic moiety. The preferred aliphatic polyisocyanate is the trimer of hexamethylene diisocyanate, the trimer of isophorone diisocyanate, the trimethylolpropane adduct of hexamethylene diisocyanate (available from Mitsui Chemicals, Inc.), or the biuret of hexamethylene diisocyanate (available from Bayer under the trade name Desmodur® N 100), of which the biuret of hexamethylene diisocyanate is more preferred.

[0144] According to another embodiment, the at least one polyisocyanate is in the form of a mixture of at least one aliphatic polyisocyanate and at least one aromatic polyisocyanate, both containing at least two or three isocyanate functional groups, such as a mixture of a biuret of hexamethylene diisocyanate and a trimethylolpropane adduct of xylylene diisocyanate, a mixture of a biuret of hexamethylene diisocyanate and a polyisocyanurate of toluene diisocyanate, and a mixture of a biuret of hexamethylene diisocyanate and a trimethylolpropane adduct of toluene diisocyanate. Most preferably, the polyisocyanate is a mixture of a biuret of hexamethylene diisocyanate and a trimethylolpropane adduct of xylylene diisocyanate. Preferably, when used as a mixture, the molar ratio of aliphatic polyisocyanate to aromatic polyisocyanate is in the range of 80:20 to 10:90.

[0145] According to another embodiment, the multifunctional monomer is an acyl chloride.

[0146] According to a particular embodiment, the method comprises: a) preparing an oil phase comprising an acyl chloride and a hydrophobic material, preferably a fragrance, to form an oil phase; b) dispersing the oil phase obtained in step a) in an aqueous phase to form an oil-in-water emulsion; c) carrying out a curing step to form microcapsules in the form of a slurry. Including, adding at least one amino compound to the aqueous phase prior to the formation of the oil-in-water emulsion and / or to the oil-in-water emulsion obtained after step b), A protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, faba bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof is added to the oil phase and / or the water phase.

[0147] The embodiments described above for the microcapsules according to the invention also apply to the method according to the invention, in particular for hydrophobic materials, proteins, acyl chlorides and amino compounds.

[0148] protein According to a particular embodiment, the protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, broad bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof is added to the oil phase and / or the water phase. According to a particular embodiment, the protein is added to the oil phase. When added to the oil phase, the protein can be pre-dispersed (or pre-dissolved) in an inert solvent or any inert perfume solvent / ingredient such as benzyl benzoate, triethyl citrate, ethyl acetate, vegetable oil (such as sunflower oil), hexyl salicylate, Neobee (caprylic / capric triglyceride), isopropyl myristate, triglycerides, D-limonene, silicone oil, mineral oil, benzyl salicylate, benzyl benzoate, cyclohexyl salicylate, benzyl phenylacetate, phenylethyl phenylacetate, triacetin, ethyl citrate, methyl and ethyl salicylates, benzyl cinnamate, and mixtures thereof, or can be mixed into the active ingredients, preferably including perfume oils.

[0149] The protein is preferably used in an amount comprised between 0.1 and 10% by weight, preferably between 0.5 and 7% by weight, based on the total weight of the oil or aqueous phase.

[0150] According to one embodiment, the protein defined in the present invention acts as a stabilizer.

[0151] However, according to one embodiment, a stabilizer may further be added to the water phase and / or the oil phase to form an emulsion. According to one embodiment, the stabilizer is a colloidal stabilizer.

[0152] By "stabilizer" is meant a compound capable of stabilizing the oil / water interface of an emulsion, typically by lowering the interfacial tension between the oil and water phases.

[0153] The terms "stabilizer" and "emulsifier" may be used interchangeably in the present invention.

[0154] According to one embodiment, the stabilizer is a colloidal stabilizer.

[0155] The colloidal stabilizer can be a polymeric emulsifier (standard emulsion), a surfactant or a solid particle (Pickering emulsion).

[0156] "Molecular emulsifier" and "polymeric emulsifier" are used interchangeably in the present invention.

[0157] "Polymer emulsifier" means an emulsifier that has both a polar group (hydrophilic) that has an affinity for water and a non-polar group (hydrophobic) that has an affinity for oil. The hydrophilic portion dissolves in the water phase, and the hydrophobic portion dissolves in the oil phase, forming a membrane around the droplets.

[0158] "Surfactant" means a non-polymeric substance containing polar and non-polar groups.

[0159] According to one embodiment, the stabilizer is selected in the group consisting of inorganic particles, polymeric emulsifiers such as polysaccharides, proteins, glycoproteins and mixtures thereof.

[0160] When the stabilizer is a solid particle, it can be selected in the group consisting of calcium phosphate, silica, silicates, titanium dioxide, aluminum oxide, zinc oxide, iron oxide, mica, kaolin, montmorillonite, laponite, bentonite, perlite, dolomite, diatomaceous earth, vermiculite, hectorite, gibbsite, illite, kaolinite, aluminosilicates, gypsum, bauxite, magnesite, talc, magnesium carbonate, calcium carbonate, diatomaceous earth and mixtures thereof.

[0161] According to certain embodiments, the stabilizer is a biopolymer.

[0162] According to a particular embodiment, the stabilizer is a polymer as defined above.

[0163] "Biopolymer" means a biological macromolecule produced by an organism. Biopolymers are characterized by a molecular weight distribution ranging from 1000 (one thousand) to 1000 million (billion) daltons. These macromolecules may be carbohydrates (sugar based) or proteins (amino acid based), or a combination of both (rubbers), and may be linear or branched.

[0164] According to one embodiment, the colloidal stabilizer is selected in the group consisting of gum arabic, modified starch, polyvinyl alcohol, polyvinylpyrrolidone (PVP), acrylamide copolymers, inorganic particles, proteins such as soy protein, rice protein, whey protein, egg albumin, sodium caseinate, gelatin, bovine serum albumin, hydrolyzed soy protein, hydrolyzed sericin, pseudo collagen, silk protein, sericin powder and mixtures thereof.

[0165] When added to the oil phase, the stabilizer can be pre-dispersed (or pre-dissolved) in an inert solvent or any inert perfume solvent / ingredient, such as benzyl benzoate, triethyl citrate, ethyl acetate, vegetable oils (such as sunflower oil), hexyl salicylate, Neobee (caprylic / capric triglyceride), isopropyl myristate, triglycerides, D-limonene, silicone oil, mineral oil, benzyl salicylate, benzyl benzoate, cyclohexyl salicylate, benzyl phenylacetate, phenylethyl phenylacetate, triacetin, ethyl citrate, methyl and ethyl salicylates, benzyl cinnamate, and mixtures thereof, or can be mixed into the active ingredients, preferably including perfume oils.

[0166] The stabilizer and acyl chloride may be premixed, preferably prior to mixing with the hydrophobic material including the perfume oil, and may be heated, for example at a temperature of 10 to 80°C.

[0167] If a colloidal stabilizer is added to the aqueous phase, it is preferably selected in the group consisting of gum arabic, modified starch, polyvinyl alcohol, polyvinylpyrrolidone (PVP), acrylamide copolymers, inorganic particles, proteins such as soy protein, rice protein, whey protein, egg albumin, sodium caseinate, gelatin, bovine serum albumin, hydrolyzed soy protein, hydrolyzed sericin, pseudo collagen, silk protein, sericin powder and mixtures thereof.

[0168] According to any one of the above embodiments of the invention, the dispersion may comprise about 0.01% to 3.0% of at least one stabilizer, preferably a colloidal stabilizer, the percentage being expressed on a w / w basis relative to the total weight of the oil-in-water emulsion as obtained after step b). In yet another aspect of the invention, the dispersion may comprise about 0.05% to 2.0%, preferably 0.05 to 1%, of at least one stabilizer, preferably a colloidal stabilizer. In yet another aspect of the invention, the dispersion may comprise about 0.1% to 1.6%, preferably 0.1% to 0.8% by weight of at least one stabilizer, preferably a colloidal stabilizer.

[0169] Acyl chloride The acyl chloride used in the present process can be defined as previously described for the microcapsules.

[0170] The weight ratio between the acyl chloride and the hydrophobic material is preferably comprised between 0.01 and 0.09, more preferably between 0.02 and 0.07.

[0171] According to a particular embodiment, the acyl chloride is used in an amount comprised between 1.7 and 7% by weight, preferably between 2.5 and 5% by weight, based on the total weight of the hydrophobic material.

[0172] The acyl chlorides can be dissolved (or dispersed) directly in the perfume oil or can be pre-dispersed (or pre-dissolved) in an inert solvent or any inert perfume solvent / ingredient, such as benzyl benzoate, triethyl citrate, ethyl acetate, vegetable oils (such as sunflower oil), hexyl salicylate, Neobee (caprylic / capric triglyceride), isopropyl myristate, triglycerides, D-limonene, silicone oils, mineral oils, benzyl salicylate, benzyl benzoate, cyclohexyl salicylate, benzyl phenylacetate, phenylethyl phenylacetate, triacetin, ethyl citrate, methyl and ethyl salicylates, benzyl cinnamate, and mixtures thereof, prior to mixing with the perfume oil.

[0173] base According to one embodiment, the aqueous phase preferably comprises a base selected in the group consisting of sodium carbonate, sodium bicarbonate, sodium hydroxide, guanidine carbonate, triethanolamine and mixtures thereof.

[0174] The base can also be added to the oil-in-water emulsion.

[0175] According to a particular embodiment, the base is not an amino compound.

[0176] According to one embodiment, the aqueous phase comprises a base, preferably selected in the group consisting of sodium carbonate, sodium bicarbonate, sodium hydroxide and mixtures thereof.

[0177] The base can be added in an amount comprised between 0.01 and 1.5% by weight, preferably between 0.01 and 0.7% by weight, based on the total weight of the aqueous phase.

[0178] Amino Compounds According to one embodiment, at least one amino compound (amino compound A) is added to the aqueous phase prior to the formation of the oil-in-water emulsion and / or to the oil-in-water emulsion obtained after step b).

[0179] According to one embodiment, the molar ratio between at least the functional group NH2 of the amino compound and the functional group COCl of the acyl chloride is comprised between 0.2 and 3, preferably between 0.5 and 2, and more preferably between 0.2 and 1.

[0180] According to one embodiment, at least one further amino compound (amino compound B) is added to the aqueous phase prior to the formation of the oil-in-water emulsion and / or to the oil-in-water emulsion obtained after step b).

[0181] According to one embodiment, at least one further amino compound (amino compound C) to the amino compounds A and B is added to the aqueous phase prior to the formation of the oil-in-water emulsion and / or to the oil-in-water emulsion obtained after step b).

[0182] According to one embodiment, the amino compounds (A and / or B and / or C) are selected in the group consisting of xylylenediamine, 1,2-diaminocyclohexane, 1,4-diaminocyclohexane, L-lysine, L-lysine ethyl ester, polyetheramines (Jeffamine®), ethylenediamine, diethylenetriamine, spermine, spermidine, polyamidoamines (PAMAM), guanidine carbonate, chitosan, tris-(2-aminoethyl)amine, 3-aminopropyltriethoxysilane, L-arginine, 1,4-diaminobutane, 2,2-dimethyl-1,3-propanediamine, 1,3-diaminopentane (Dytek EP Diamine), 1,2-diaminopropane, triethylenetetramine, amines with disulfide bonds, such as cystamine, cystamine hydrochloride, cystine, cystine hydrochloride, cystine dialkyl esters, cystine dialkyl ester hydrochlorides, and mixtures thereof.

[0183] According to one embodiment, the amino compounds (A and / or B and / or C) are cystamine, cystamine hydrochloride, cystine, cystine hydrochloride, cystine dialkyl esters, cystine dialkyl ester hydrochlorides, xylylenediamine, 1,2-diaminocyclohexane, 1,4-diaminocyclohexane, polyetheramines, ethylenediamine, diethylenetriamine, spermine, spermidine, polyamidoamine (PAMAM), guanidine carbonate, chitosan, tris-(2-aminoethyl)amine, 3-aminopropyltriethoxysilane, 1,4-diaminobutane, 2,2-dimethyl-1,3-propanediamine, 1,3-diaminopentane (Dytek EP diamine), 1,2-diaminopropane, triethylenetetramine, 1,3-diaminopropane; urea; ethyleneurea; aminoguanidine bicarbonate; 1-(2-aminoethyl)imidazolidin-2-one; N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine; N1-(2-aminoethyl)-N1-dodecyl-1,2-ethanediamine; aminoethylethanolamine; N1-(3-aminopropyl)propane-1,3-diamine, polyethyleneimine, amino acids such as L-lysine, L-arginine, L-histidine, L-tryptophan, L-serine, L-glutamine, L-threonine, L-leucine and / or their derived oligomers and polymers and mixtures thereof.

[0184] According to one embodiment, at least one amino compound (amino compound A) is added to the aqueous phase prior to the formation of the oil-in-water emulsion and / or to the oil-in-water emulsion obtained after step b).

[0185] According to one embodiment, at least one amino compound (amino compound A), preferably an amino acid, more preferably L-lysine, is added to the aqueous phase prior to the formation of the oil-in-water emulsion and at least one amino compound (amino compound B) or at least two amino compounds (amino compound B and amino compound C) are added to the aqueous phase prior to the formation of the oil-in-water emulsion and / or to the oil-in-water emulsion obtained after step b), wherein amino compound B is preferably ethylenediamine and amino compound C is preferably diethylenetriamine.

[0186] The base may also be added to the aqueous phase and / or the oil-in-water emulsion.

[0187] According to one embodiment, the molar ratio between the functional group NH2 of ethylenediamine and diethylenetriamine (EDA+DETA) and the functional group COCl of the acyl chloride is comprised between 0.2 and 3, preferably between 0.5 and 2, more preferably between 0.2 and 1.

[0188] According to a particular embodiment, a multivalent salt (calcium chloride, magnesium chloride, zinc chloride, iron trichloride, etc.) is added after step b) and before or during step c).

[0189] carbohydrates According to one embodiment, carbohydrates are added to the aqueous and / or oil phase.

[0190] According to one embodiment, "carbohydrate" is to be understood as a polymer or oligomer having more than two units.

[0191] According to another embodiment, the carbohydrate, the amino compound A and the amino compound B are different moieties.

[0192] According to one embodiment, at least one carbohydrate is added to the oil phase and / or the water phase.

[0193] According to one embodiment, the carbohydrate is not a polyphenol.

[0194] According to one embodiment, the carbohydrate is not a functionalized carbohydrate.

[0195] According to one embodiment, the carbohydrate is a polysaccharide.

[0196] According to one embodiment, the polysaccharide is an anionic polysaccharide.

[0197] According to a particular embodiment, the polysaccharide is added to the aqueous phase.

[0198] The polysaccharide is preferably selected in the group consisting of anionic salts of alginic acid, preferably sodium alginate, pectin, lignin, anionically modified starch, carboxymethylcellulose and mixtures thereof.

[0199] According to a particular embodiment, the carbohydrate is an anionic salt of alginic acid, preferably sodium alginate.

[0200] "Sodium alginate" and "sodium alginate" may be used interchangeably.

[0201] According to a particular embodiment, the carbohydrate is used in an amount comprised between 0.1 and 5% by weight, preferably between 0.5 and 1.1% by weight, based on the total weight of the aqueous phase.

[0202] Multiple microcapsule system According to one embodiment, the microcapsules of the present invention (first type of microcapsules) may be used in combination with a second type of microcapsules.

[0203] Another subject of the present invention is - microcapsules of the invention as a first type of microcapsule, - a second type of microcapsule; wherein the first type of microcapsules and the second type of microcapsules differ in their hydrophobic material and / or their wall material and / or their coating material.

[0204] According to certain embodiments, the microcapsule delivery system is in the form of a slurry.

[0205] The wall of the second type of microcapsules may be different. As a non-limiting example, the polymer shell of the second type of microcapsule comprises a material selected from the group consisting of polyurea, polyurethane, polyamide, polyhydroxyalkanoate, polyacrylate, polyester, polyaminoester, polyepoxide, polysiloxane, polycarbonate, polysulfonamide, urea formaldehyde, melamine formaldehyde resin, melamine formaldehyde resin crosslinked with polyisocyanate or aromatic polyol, melamine urea resin, melamine glioxal resin, gelatin / gum arabic shell wall and mixtures thereof.

[0206] The second type of microcapsule may comprise an oily core comprising a hydrophobic active agent, preferably a fragrance, and a composite shell comprising a first material and a second material, the first material being a coacervate and the second material being a polymeric material, the first and second materials being different from each other. In a particular embodiment, the weight ratio of the first material to the second material is comprised between 50:50 and 99.9:0.1. In a particular embodiment, the coacervate comprises a first polyelectrolyte, preferably selected from proteins (such as gelatin), polypeptides or polysaccharides (such as chitosan), most preferably gelatin, and a second polyelectrolyte, preferably an alginate, a cellulose derivative, a guar gum, a pectinate, a carrageenan, a polyacrylic acid and a methacrylic acid, or a xanthan gum, or even a vegetable gum, such as gum acacia (gum arabic), most preferably gum arabic. The coacervate of the first material can be chemically hardened using a suitable crosslinking agent such as glutaraldehyde, glyoxal, formaldehyde, tannic acid or genipin, or enzymatically hardened using an enzyme such as transglutaminase. The second polymeric material can be selected from the group consisting of polyureas, polyurethanes, polyamides, polyesters, polyacrylates, polysiloxanes, polycarbonates, polysulfonamides, polymers of urea and formaldehyde, melamine and formaldehyde, melamine and urea or melamine and glyoxal, and mixtures thereof, preferably polyureas and / or polyurethanes. The second material is preferably present in an amount of less than 3% by weight, preferably less than 1% by weight, based on the total weight of the slurry of second type of microcapsules.

[0207] As non-limiting examples, the shell of the second type of microcapsules can be aminoplast-based, polyurea-based or polyurethane-based. The shell of the second type of microcapsules can also be hybrid, i.e. organic-inorganic, such as a hybrid shell composed of at least two types of inorganic particles crosslinked, or even a shell obtained by hydrolysis and condensation reactions of polyalkoxysilane macromonomer compositions.

[0208] According to one embodiment, the shell of the second type of microcapsule comprises an aminoplast copolymer, such as melamine-formaldehyde or urea-formaldehyde or crosslinked melamine formaldehyde or melamine glioxal.

[0209] According to another embodiment, the shell of the second type of microcapsule is polyurea-based, for example, but not limited to, made of isocyanate-based monomers and amine-containing crosslinkers such as guanidine carbonate and / or guanazole. Certain polyurea microcapsules comprise a polyurea wall that is the reaction product of polymerization between at least one polyisocyanate containing at least two isocyanate functional groups and at least one reactant selected from the group consisting of amines (e.g., water-soluble guanidine salts and guanidine); colloidal stabilizers or emulsifiers; and encapsulated fragrances. However, the use of amines can be omitted. According to a particular embodiment, the colloidal stabilizer comprises an aqueous solution of 0.1% to 0.4% polyvinyl alcohol, 0.6% to 1% cationic copolymer of vinylpyrrolidone and quaternized vinylimidazole (all percentages defined by weight relative to the total weight of the colloidal stabilizer). According to another embodiment, the emulsifier is an anionic or amphiphilic biopolymer, which in one embodiment may be selected from the group consisting of gum arabic, soy protein, gelatin, sodium caseinate and mixtures thereof.

[0210] According to another embodiment, the microcapsule wall material of the second type of microcapsule may comprise any suitable resin, including in particular melamine, glyoxal, polyurea, polyurethane, polyamide, polyester, etc. Suitable resins include reaction products of aldehydes and amines, suitable aldehydes include formaldehyde and glyoxal. Suitable amines include melamine, urea, benzoguanamine, glycoluril, and mixtures thereof. Suitable melamines include methylol melamine, methylated methylol melamine, imino melamine, and mixtures thereof. Suitable ureas include dimethylol urea, methylated dimethylol urea, urea-resorcinol, and mixtures thereof. Materials suitable for fabrication can be obtained from one or more of the following companies: Solutia Inc. (St Louis, Missouri USA), Cytec Industries (West Paterson, New Jersey USA), Sigma-Aldrich (St. Louis, Missouri USA).

[0211] According to another embodiment, the second type of microcapsules comprises: 1) combining a perfume oil with at least one polyisocyanate having at least two isocyanate functional groups to form an oil phase; 2) dispersing or dissolving an aminoplast resin and, optionally, a stabilizer in water to form an aqueous phase; 3) preparing an oil-in-water dispersion having an average droplet size comprised between 1 and 100 microns by mixing an oil phase and an aqueous phase; 4) performing a curing step to form the walls of the microcapsules; 5) Optionally, drying the final dispersion to obtain dry core-shell microcapsules. and (b) preparing one-shell aminoplast core-shell microcapsules comprising:

[0212] According to one embodiment, the second type of microcapsules are formaldehyde-free capsules. A typical process for preparing a slurry of aminoplast formaldehyde-free microcapsules is: 1) a. a polyamine component in the form of melamine or a mixture of melamine and at least one C1-C4 compound containing two NH2 functional groups; b. Glyoxal, C 4~6 An aldehyde component in the form of a mixture of 2,2-dialkoxy-ethanal and optionally glyoxalate, said mixture having a glyoxal / C ratio of 1 / 1 to 10 / 1. 4~6 an aldehyde component having a molar ratio of 2,2-dialkoxy-ethanal; and c. Protonic acid catalyst preparing an oligomeric composition comprising or obtained by reacting the reaction product of 2) The droplet size is between 1 and 600 microns; a. Oil, b.Aqueous medium, c. at least one oligomeric composition obtained in step 1; d. i.C4~C 12 Aromatic or aliphatic di- or tri-isocyanates, and their biuret, triuret, trimer, trimethylolpropane adducts, and mixtures thereof, and / or ii.Formula: A-(Oxirane-2-ylmethyl) n [In the formula, n represents 2 or 3, and A represents a C2-C6 group optionally containing 2-6 nitrogen and / or oxygen atoms. Di- or tri-oxirane compounds of at least one crosslinking agent selected from e. Optionally, a C1-C4 compound containing two NH2 functional groups preparing an oil-in-water dispersion comprising: 3) heating the dispersion; 4) cooling the dispersion; Includes.

[0213] In another particular embodiment, the second type of microcapsules comprises: an oily core containing a hydrophobic active agent, preferably a fragrance; - optionally an inner shell made of polymerized multifunctional monomers, - a protein-containing biopolymer shell, cross-linked by at least one protein; Includes.

[0214] According to a particular embodiment, the protein is selected in the group consisting of milk proteins, caseinates such as sodium or calcium caseinate, casein, whey proteins, hydrolyzed proteins, gelatin, gluten, pea proteins, soy proteins, silk proteins and mixtures thereof, preferably sodium caseinate, most preferably sodium caseinate.

[0215] According to a particular embodiment, the proteins include sodium caseinate and preferably globular proteins selected in the group consisting of whey protein, beta-lactoglobulin, ovalbumin, bovine serum albumin, vegetable proteins, and mixtures thereof.

[0216] The protein is preferably a mixture of sodium caseinate and whey protein.

[0217] According to a particular embodiment, the biopolymer shell comprises cross-linked proteins selected in the group consisting of sodium caseinate and / or whey protein.

[0218] According to a particular embodiment, the slurry of the second type of microcapsules is an oily core containing a hydrophobic active agent, preferably a fragrance; - an inner shell made of polymerized multifunctional monomers, preferably polyisocyanates having at least two isocyanate functional groups; - a biopolymer shell comprising at least one protein cross-linked, the protein preferably comprising a mixture comprising sodium caseinate and a globular protein, preferably whey protein; - optionally at least one outer mineral layer The composition comprises at least one microcapsule made of

[0219] According to one embodiment, the sodium caseinate and / or whey protein are cross-linked proteins.

[0220] The weight ratio of sodium caseinate to whey protein is preferably comprised between 0.01 and 100, preferably between 0.1 and 10, more preferably between 0.2 and 5.

[0221] In another particular embodiment, the second type of microcapsules comprises: an oily core containing a hydrophobic active agent, preferably a fragrance; - a polyamide shell, Acyl chlorides, a first amino compound, and ·Second Amino Compound and a polyamide shell comprising or derived therefrom. The polyamide core-shell polyamide microcapsule comprises:

[0222] According to a particular embodiment, the second type of microcapsules comprises: an oily core containing a hydrophobic active agent, preferably a fragrance; - a polyamide shell, Acyl chloride in an amount of preferably 5 to 98%, preferably 20 to 98%, more preferably 30 to 85% (w / w), the first amino compound in an amount preferably between 1% and 50% (w / w), preferably between 7 and 40% (w / w); a second amino compound in an amount preferably between 1% and 50% (w / w), preferably between 2 and 25% (w / w), A stabilizer, preferably a biopolymer, in an amount preferably between 0 and 90%, preferably between 0.1 and 75%, more preferably between 1 and 70%. and a polyamide shell comprising or derived therefrom. Includes.

[0223] According to a particular embodiment, the second type of microcapsules comprises: an oily core containing a hydrophobic active agent, preferably a fragrance; - a polyamide shell, Acyl chlorides, a first amino compound selected from the group consisting of amino acids, preferably L-lysine, L-arginine, L-histidine, L-tryptophan and / or mixtures thereof, a second amino compound selected from the group consisting of ethylenediamine, diethylenetriamine, cystamine and / or mixtures thereof, and A biopolymer selected from the group consisting of casein, sodium caseinate, bovine serum albumin, whey protein and / or mixtures thereof. and a polyamide shell comprising or derived therefrom. Includes.

[0224] According to another embodiment, the shell of the second type of microcapsule is polyurea or polyurethane based. Examples of methods for preparing polyurea and polyurethane based microcapsule slurries are described, for example, in WO 2007 / 004166, EP 2300146 and EP 25799. Typically, the method for preparing polyurea or polyurethane based microcapsule slurries comprises the following steps: a) dissolving at least one polyisocyanate having at least two isocyanate groups in oil to form an oil phase; b) preparing an aqueous solution of an emulsifier or colloidal stabilizer to form an aqueous phase; c) adding an oil phase to an aqueous phase to form an oil-in-water dispersion with an average droplet size comprised between 1 and 500 μm, preferably between 5 and 50 μm; and d) applying conditions sufficient to induce interfacial polymerization to form microcapsules in the form of a slurry.

[0225] Perfuming compositions and consumer products The microcapsules of the invention can be used in combination with active ingredients. The subject of the invention is therefore (i) microcapsules or a microcapsule slurry as defined above, (ii) an active ingredient, preferably selected from the group consisting of cosmetic ingredients, skin care ingredients, fragrance ingredients, flavor ingredients, deodorant ingredients, bactericidal ingredients, fungicidal ingredients, pharmaceutical or pesticide ingredients, disinfecting ingredients, insect repellents or attractants, and mixtures thereof; A composition comprising:

[0226] The capsules of the present invention exhibit good performance in terms of stability in hostile media.

[0227] Another subject of the present invention is (i) a microcapsule or microcapsule slurry as defined above, wherein the oil contains a fragrance; (ii) at least one ingredient selected from the group consisting of perfume carriers, perfume co-ingredients, and mixtures thereof; (iii) optionally, at least one flavoring adjuvant; A fragrance composition comprising:

[0228] Liquid perfume carriers can include, as non-limiting examples, emulsifying systems, i.e., solvent and surfactant systems, or solvents commonly used in perfumery. A detailed description of the nature and type of solvents commonly used in perfumery cannot be comprehensive. However, as non-limiting examples, the most commonly used solvents can be dipropylene glycol, diethyl phthalate, isopropyl myristate, benzyl benzoate, 2-(2-ethoxyethoxy)-1-ethanol or ethyl citrate. For compositions that include both perfume carriers and perfume co-ingredients, suitable perfume carriers other than those specified above can also be ethanol, water / ethanol mixtures, limonene or other terpenes, isoparaffins such as those known under the trademark Isopar® (supplied by Exxon Chemical), or glycol ethers and glycol ether esters such as those known under the trademark Dowanol® (supplied by Dow Chemical Company). By "perfume co-ingredient" is meant herein a compound that is used in perfume preparations or compositions to impart a hedonic effect and is not a microcapsule as defined above. In other words, to be considered a perfuming co-ingredient, such a co-ingredient must not only have an odor, but must also be recognized by those skilled in the art as being at least capable of imparting or modifying the odor of the composition in a positive or pleasant way.

[0229] The nature and type of perfuming co-ingredients present in the perfuming composition do not require a more detailed description here, and are in any case not comprehensive, and a person skilled in the art can select them based on his general knowledge, depending on the intended use or application, and the desired organoleptic effect.Generally, these perfuming co-ingredients belong to various chemical classes, such as alcohols, lactones, aldehydes, ketones, esters, ethers, acetates, nitriles, terpenoids, nitrogen-containing or sulfur-containing heterocyclic compounds, and essential oils, and said perfuming co-ingredients can be of natural or synthetic origin.Many of these co-ingredients are described in any case in reference literature, for example in the book Perfume and Flavor Chemicals, 1969, Montclair, New Jersey, USA, by S. Arctander, or its more recent editions, or other treatises of the same kind, and in the abundant patent literature in the field of perfumery.It is also understood that said co-ingredients may be compounds known to release various kinds of perfuming compounds in a controlled manner. The co-ingredients are 4-(dodecylthio)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-butanone, 4-(dodecylthio)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butanone, trans-3-(dodecylthio)-1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-1-butanone, 2-(dodecylthio)octan-4-one, 2-phenylethyloxo(phenyl)acetate, 3,7-dimethylocta-2,6-dien-1-yloxo(phenyl)acetate, (Z)-hex-3-en-1-yloxo(phenyl)acetate, 3,7-dimethyl-2,6-octadien-1-ylhexadecanoate, bis(3,7-dimethylocta-2,6-dien-1-yl)succinate, (2-((2-methylundec-1-en-1-yl)oxy)ethyl)benzene, 1-methoxy-4-(3-methyl-4-phenethoxybut-3-en-1-yl)benzene, (3-methyl-4-phenethoxybut-3-en-1-yl)benzene, 1-(((Z)-hex-3-en-1-yl)oxy)-2-methylundec-1-ene, (2-((2-methyl undec-1-en-1-yl)oxy)ethoxy)benzene, 2-methyl-1-(octan-3-yloxy)undec-1-ene, 1-methoxy-4-(1-phenethoxyprop-1-en-2-yl)benzene, 1-methyl-4-(1-phenethoxyprop-1-en-2-yl)benzene, 2-(1-phenethoxyprop-1-en-2-yl)naphthalene, (2-phenethoxyvinyl)benzene, 2-(1-((3,7-dimethyloct-6-en-1-yl)oxy)prop-1-en-2-yl)naphthalene, (2-((2-pentylcyclopentylidene)methoxy)ethyl)benzene, 4-allyl-2-methoxy-1-((2-methoxy-2-phenylvinyl)oxy)benzene, (2-((2-heptylcyclopentylidene)methoxy)ethyl)benzene, 1-isopropyl-4-methyl-2-((2-pentylcyclopentylidene)methoxy)benzene, 2-methoxy-1-((2-pentylcyclopentylidene)methoxy)-4-propylbenzene, 3-methoxy-4-((2-methoxy-2-phenylvinyl)oxy)benzaldehyde, 4-((2-(hexyloxy)-2-phenylvinyl)oxy)-3-methoxybenzaldehyde or mixtures thereof.

[0230] By "perfuming adjuvant" is meant herein an ingredient capable of imparting additional added benefits such as color, specific light resistance, chemical stability, etc. A detailed description of the nature and type of adjuvants commonly used in perfuming bases cannot be comprehensive, but it is necessary to mention that said ingredients are well known to those skilled in the art.

[0231] Preferably, the perfuming composition according to the invention comprises 0.01 to 30% by weight of microcapsules as defined above.

[0232] The microcapsules of the present invention can be advantageously used in many fields of application and can be used in consumer products: they can be used in liquid form, which is applicable in liquid consumer products, and also in powder form, which is applicable in powder consumer products.

[0233] According to a particular embodiment, the consumer product defined above is a liquid, a) 2 to 65% by weight, based on the total weight of the consumer product, of at least one surfactant; b) water or a water-miscible hydrophilic organic solvent; c) a microcapsule slurry or microcapsules as defined above; d) optionally, a non-encapsulated flavoring; Includes.

[0234] According to a particular embodiment, the consumer product defined above is in powder form, a) 2 to 65% by weight, based on the total weight of the consumer product, of at least one surfactant; b) a microcapsule powder as defined above, c) Optionally, a flavor powder different from the microcapsules defined above. Includes.

[0235] In the case of microcapsules containing a perfume oil-based core, the products of the invention can be used in particular in perfumed consumer products, such as those belonging to fine fragrances or "functional" perfumery. Functional perfumery includes in particular personal care products, including hair care, body cleansing, skin care, hygiene care, and home care products, including laundry care, surface care and air care. As a result, another subject of the invention consists of perfumed consumer products, which contain, as perfuming ingredient, a microcapsule as defined above or a perfuming composition as defined above. The perfume element of said consumer products may be a combination of perfume microcapsules as defined above and non-encapsulated or non-encapsulated perfumes, as well as perfume microcapsules of other types than those disclosed herein.

[0236] especially, a) 2 to 65% by weight, based on the total weight of the consumer product, of at least one surfactant; b) water or a water-miscible hydrophilic organic solvent; c) a flavoring composition as defined above; A liquid consumer product comprising the compound is another subject of the present invention.

[0237] Also, (a) 2 to 65 weight percent of at least one surfactant, based on the total weight of the consumer product; (b) a flavouring composition as defined above; A powdered consumer product comprising the compound is part of the present invention.

[0238] Thus, the microcapsules of the present invention can be added to perfumed consumer products either as such or as part of the perfume composition of the present invention.

[0239] For the sake of clarity, it is necessary to mention that by "perfumed consumer product" it is meant a consumer product which is expected to provide, among other benefits, a perfuming effect on the surface to which it is applied (for example skin, hair, fabric, paper or residential surfaces) or in the air (air freshener sprays, deodorants, etc.) In other words, the perfumed consumer product according to the invention is a manufactured article comprising a functional formulation, also called a "base", together with a benefit agent, among other things an effective amount of the microcapsules according to the invention.

[0240] The nature and type of other components of the perfumed consumer product do not require a more detailed description herein, and are in any case not comprehensive, and a person skilled in the art can select them based on general knowledge, depending on the nature and desired effect of said product.The basic formulations of consumer products that can incorporate the microcapsules of the present invention can be found in the abundant literature on such products.These formulations do not require a more detailed description herein, and are in any case not comprehensive.A person skilled in the formulation of such consumer products is entirely capable of selecting suitable ingredients based on general knowledge and available literature.

[0241] Non-limiting examples of suitable perfumed consumer products include perfumes, such as fine perfumes, colognes, aftershaves, body splashes; fabric care products, such as liquid or solid detergents, tablets and unit doses (single or multi-chamber), fabric softeners, dryer sheets, fabric deodorants, ironing waters or bleaches; personal care products, such as hair care products (e.g. shampoos, hair conditioners, colorants or hairsprays), cosmetics (e.g. vanishing creams, body lotions, or deodorants or antiperspirants), or It may be a skin care product (e.g. a perfumed soap, a shower or bath smooth, a body wash, an oil or gel, a bath salt, or a hygiene product); an air care product, e.g. a deodorising spray, or a "ready to use" powder deodorising spray; or a home care product, e.g. an all-purpose cleaner, a liquid or powder or tablet dishwashing product, a toilet cleaner, or a product for cleaning various surfaces, e.g. sprays & wipes for treating / refreshing fabrics or hard surfaces (floors, tiles, stone paving, etc.); a hygiene product, e.g. sanitary napkins, diapers, toilet paper.

[0242] Another subject of the present invention is - a personal care active base; - a microcapsule or a microcapsule slurry as defined above, or a perfuming composition as defined above; A consumer product comprising: The consumer product is in the form of a personal care composition.

[0243] The personal care active bases in which the microcapsules of the present invention can be incorporated can be found in the abundant literature on such products.These formulations do not require detailed description here, and are in any case not comprehensive.Those skilled in the formulation of such consumer products are entirely capable of selecting suitable ingredients based on general knowledge and available literature.

[0244] The personal care composition is preferably selected in the group consisting of a hair care product (e.g. shampoo, hair conditioner, colorant or hairspray), a cosmetic product (e.g. vanishing cream, body lotion, or deodorant or antiperspirant), or a skin care product (e.g. perfumed soap, shower or bath smooth, body wash, oil or gel, bath salts, or hygiene product).

[0245] Another subject of the present invention is - a home or fabric care active base; - a microcapsule or a microcapsule slurry as defined above, or a perfuming composition as defined above; A consumer product comprising: The consumer product is in the form of a home care or fabric care composition.

[0246] Home care or fabric care active bases in which the microcapsules of the present invention can be incorporated can be found in the abundant literature on such products. Their formulations do not require a detailed description here, and are in any case not comprehensive. Those skilled in the formulation of such consumer products are entirely capable of selecting suitable ingredients based on general knowledge and available literature.

[0247] Preferably, the consumer product comprises 0.1-15% by weight, more preferably 0.2-5% by weight, of the microcapsules of the invention, these percentages being defined by weight relative to the total weight of the consumer product. Of course, the above concentrations can be adapted depending on the beneficial effect desired for each product.

[0248] A subject of the present invention is a consumer product, preferably a home care or fabric care consumer product, comprising a microcapsule or a microcapsule slurry as defined above, wherein the consumer product has a pH of less than 7.

[0249] A subject of the present invention is a consumer product, preferably a home care or fabric care consumer product, comprising microcapsules or a microcapsule slurry as defined above, wherein the consumer product has a pH of 7 or higher.

[0250] For the liquid consumer products described below, by "active base" it should be understood that the active base comprises active ingredients (typically including surfactants) and water.

[0251] With respect to the solid consumer products described below, by "active base" it should be understood that the active base includes active materials (which typically include surfactants) and adjuvants (such as bleaches, buffers; builders; stain removing or stain suspending polymers; granular enzyme particles, rust inhibitors, antifoam agents, suds suppressors; dyes, fillers and mixtures thereof).

[0252] Fabric softener The subject of the present invention is a fabric softener active base, preferably comprising at least one active material selected from the group consisting of dialkyl quaternary ammonium salts, dialkyl ester quaternary ammonium salts (ester quats), Hamburg esterquats (HEQ), TEAQ (triethanolamine quats), silicones and mixtures thereof, preferably used in an amount comprised between 85 and 99.95% by weight, based on the total weight of the composition; - a microcapsule slurry or microcapsules as defined above, preferably in an amount comprised between 0.05 and 15% by weight, more preferably between 0.1 and 5% by weight, based on the total weight of the composition, - optionally, unencapsulated perfume oil and a fabric softener composition comprising:

[0253] Liquid detergent The subject of the present invention is a liquid detergent active base, preferably comprising at least one active material chosen from the group consisting of anionic surfactants such as alkylbenzenesulfonates (ABS), secondary alkylsulfonates (SAS), primary alcohol sulfates (PAS), lauryl ether sulfates (LES), methyl ester sulfonates (MES), and non-ionic surfactants such as alkylamines, alkanolamides, fatty alcohol poly(ethylene glycol) ethers, fatty alcohol ethoxylates (FAE), ethylene oxide (EO) and propylene oxide (PO) copolymers, amine oxides, alkyl polyglucosides, alkyl polyglucosamides, preferably used in an amount comprised between 85 and 99.95% by weight, based on the total weight of the composition; - a microcapsule slurry or microcapsules as defined above, preferably in an amount comprised between 0.05 and 15% by weight, more preferably between 0.1 and 5% by weight, based on the total weight of the composition, - optionally, unencapsulated perfume oil A consumer product in the form of a liquid detergent composition comprising:

[0254] Solid detergent The subject of the present invention is a solid detergent active base, preferably comprising at least one active material chosen from the group consisting of anionic surfactants such as alkylbenzenesulfonates (ABS), secondary alkylsulfonates (SAS), primary alcohol sulfates (PAS), lauryl ether sulfates (LES), methyl ester sulfonates (MES), and non-ionic surfactants such as alkylamines, alkanolamides, fatty alcohol poly(ethylene glycol) ethers, fatty alcohol ethoxylates (FAE), ethylene oxide (EO) and propylene oxide (PO) copolymers, amine oxides, alkyl polyglucosides, alkyl polyglucosamides, and preferably used in an amount comprised between 85 and 99.95% by weight, based on the total weight of the composition; - a microcapsule powder or a microcapsule slurry or a microcapsule as defined above, preferably in an amount comprised between 0.05 and 15% by weight, more preferably between 0.1 and 5% by weight, based on the total weight of the composition, - optionally, unencapsulated perfume oil and a solid detergent composition comprising:

[0255] Shampoo / Shower gel The subject of the present invention is a shampoo or shower gel active base, preferably comprising at least one active material chosen from the group consisting of sodium alkyl ether sulfates, ammonium alkyl ether sulfates, alkyl amphoacetates, cocamidopropyl betaine, cocamide MEA, alkyl glucosides and amino acid surfactants, and mixtures thereof, preferably used in an amount comprised between 85 and 99.95% by weight, based on the total weight of the composition; - a microcapsule slurry or microcapsules as defined above, preferably in an amount comprised between 0.05 and 15% by weight, more preferably between 0.1 and 5% by weight, based on the total weight of the composition, - optionally, unencapsulated perfume oil A consumer product in the form of a shampoo or shower gel composition comprising:

[0256] Rinse-off conditioner The subject of the present invention is a rinse-off conditioner active base, preferably comprising at least one active material selected from the group consisting of cetyltrimonium chloride, stearyltrimonium chloride, benzalkonium chloride, behentrimonium chloride and mixtures thereof, preferably used in an amount comprised between 85 and 99.95% by weight based on the total weight of the composition, - a microcapsule slurry or microcapsules as defined above, preferably in an amount comprised between 0.05 and 15% by weight, more preferably between 0.1 and 5% by weight, based on the total weight of the composition, - optionally, unencapsulated perfume oil and a rinse-off conditioner composition comprising:

[0257] Solid fragrance enhancer The subject of the present invention is - solid carriers, preferably selected from the group consisting of urea, sodium chloride, sodium sulfate, sodium acetate, zeolites, sodium carbonate, sodium bicarbonate, clays, talc, calcium carbonate, magnesium sulfate, gypsum, calcium sulfate, magnesium oxide, zinc oxide, titanium dioxide, calcium chloride, potassium chloride, magnesium chloride, zinc chloride, sugars, such as sucrose, mono-, di- and polysaccharides, and derivatives, such as starch, cellulose, methylcellulose, ethylcellulose, propylcellulose, polyols / sugar alcohols, such as sorbitol, maltitol, xylitol, erythritol and isomalt, PEG, PVP, citric acid, or any water-soluble solid acid, fatty alcohol or fatty acid, and mixtures thereof, - a microcapsule slurry or microcapsules as defined above, preferably in the form of a powder in an amount comprised between 0.05 and 15% by weight, more preferably between 0.1 and 5% by weight, based on the total weight of the composition, - optionally, unencapsulated perfume oil A consumer product in the form of a solid fragrance enhancer composition comprising:

[0258] Liquid fragrance enhancer The subject of the present invention is an aqueous phase; - a surfactant system consisting essentially of one or more non-ionic surfactants having an average HLB between 10 and 14, preferably selected in the group consisting of ethoxylated fatty alcohols, POE / PPG (polyoxyethylene and polyoxypropylene) ethers, mono- and polyglyceryl esters, sucrose ester compounds, polyoxyethylene hydroxyesters, alkyl polyglucosides, amine oxides, and combinations thereof; - a linker selected from the group consisting of alcohols, salts and esters of carboxylic acids, salts and esters of hydroxyl carboxylic acids, fatty acids, fatty acid salts, glycerol fatty acids, surfactants with an HLB of less than 10, and mixtures thereof; - a microcapsule slurry or microcapsules as defined above, preferably in the form of a slurry, in an amount comprised between 0.05 and 15% by weight, more preferably between 0.1 and 5% by weight, based on the total weight of the composition; - optionally with non-encapsulated perfume oil and a liquid fragrance enhancer composition comprising:

[0259] Hair Coloring The subject of the present invention is - an oxidizing phase comprising an oxidizing agent and an alkaline phase comprising an alkalizing agent, a dye precursor and a coupling compound, said dye precursor and said coupling compound forming an oxidizing hair dye in the presence of an oxidizing agent, preferably in an amount comprised between 85 and 99.95% by weight, based on the total weight of the composition, - microcapsules or a microcapsule slurry as defined above, preferably in an amount comprised between 0.05 and 15% by weight, more preferably between 0.1 and 5% by weight, based on the total weight of the composition, - optionally, unencapsulated perfume oil and a consumer product in the form of an oxidative hair coloring composition comprising:

[0260] Perfuming composition According to a particular embodiment, the consumer product comprises: - 0.1 to 30%, preferably 0.1 to 20%, of microcapsules or a microcapsule slurry as defined above, - 0-40%, preferably 3-40% fragrance, and 20 to 90% by weight, preferably 40 to 90% by weight, of ethanol, based on the total weight of the perfuming composition The fragrance composition is in the form of a fragrance composition comprising:

[0261] The invention will now be further illustrated by examples, it being understood that the invention as claimed is not intended to be limited in any way by these examples.

[0262] Working Example General protocol: The protein was optionally dispersed in an inert solvent (e.g. benzyl benzoate (BB) or Neobee) and kept under stirring at 60°C for 30 minutes. This solution and a polyfunctional monomer (e.g.: Benzene-1,3,5-tricarbonyl chloride-BTC) were added to perfume oil (25g or 30g - see Table 1) at room temperature to form an oil phase. The oil phase was mixed with water (94g), the latter containing at least one amino compound (first amino compound) and optionally a base. The reaction mixture was stirred with an Ultra Turrax at 24,000 rpm for 30 seconds or 1 minute to obtain an emulsion. At least one amino compound (second amino compound and optionally a third amino compound) was dissolved in water (5g) and this solution was added dropwise to the emulsion. The reaction mixture was stirred at 60°C for 4 hours to obtain a white dispersion.

[0263] A second and optionally a third amino compound can also be added to the aqueous phase prior to the emulsification step (see capsules F2-F5).

[0264] [Table 1]

[0265] Example 1 Preparation of polyamide microcapsules (using potato protein as protein) [Table 2-1] [Table 2-2]

[0266] Example 2 Preparation of polyamide microcapsules (using chickpea protein as protein) [Table 3]

[0267] Example 3 Preparation of polyamide microcapsules (using pea protein as protein) [Table 4]

[0268] Example 4 Preparation of polyamide microcapsules [Table 5]

[0269] Example 5 Preparation of polyamide microcapsules (using pretreated potato protein as protein) [Table 6]

[0270] Modification process: A 2% protein solution is made and NaCl is added to a concentration of 100 mmol / l. The solution is heated at 90° C. for 90 minutes. After cooling, the pH of the solution is adjusted to 9.5 with 1 M NaOH. The solution is then freeze-dried (the solution can also be spray-dried).

[0271] Example 6 Preparation of polyamide microcapsules [Table 7]

[0272] Example 7 Stable performance The microcapsules of the present invention are dispersed in the fabric softener composition set forth in Table 8 to obtain a concentration of 0.116% encapsulated perfume oil.

[0273] [Table 8]

[0274] protocol: Sample Extraction: The internal standard (ISTD) used for quantification was ethyl dodecanoate. 2 g of sample was weighed in three portions into 20 mL bottle flasks and extracted with 10 mL of 9 / L isooctane / diethyl ether solution containing 5 mg / L ISTD. The samples were then shaken in a Turbulat (1 h, speed 52 rpm) and then left to stand for 15-30 min until completely decanted. The top of the organic layer was sampled with a 2 mL syringe and filtered through a 0.20 μm PTFE filter into a GC vial. Sample extraction was performed in triplicate.

[0275] Analysis conditions: The analysis was performed on a gas chromatograph with a 7890 B Agilent instrument connected to a 5977B MS detector. The instrument was equipped with a pneumatic control module to ensure a backflush system and two 15 m × 250 μm × 0.25 μm DB-1MS columns. Helium was used as the carrier gas, with an inlet temperature of 250 °C and a pressure of 10.3 psi. Split mode was set with a split ratio of 20:1 and a split flow rate of 20 mL / min, with the gas saver activated after 2 min at a flow rate of 15 mL / min. The oven program was 50 °C for 5 min, 15 °C / min to 230 °C, 1 min at 230 °C, with a 4 min post-run backflush, then column flows to the MSD and inlet were 3.45 mL / min and -3.05 mL / min, respectively, with a 30 psi auxiliary pressure. The MS temperatures were 150 °C for the quadrupole and 230 °C for the ion source, with a scan range of 25-450 m / z and a solvent delay of 4 min.

[0276] calibration: Samples were quantified with a standard curve. Calibration and validation points were prepared in 9 l isooctane / diethyl ether solution containing 5 mg / L ISTD (first method).

[0277] A second calibration was prepared with a softener base and extracted following the same protocol as the samples, and was compared and confirmed with the results obtained with the first method.

[0278] [Table 9]

[0279] It can be concluded that the microcapsules of the present invention show good stability in a challenging base.

[0280] Example 8 Biodegradability of the microcapsules according to the present invention Shell Extraction (Following the method disclosed in Gasparini and all in Molecules 2020, 25,718) The aqueous phase of the microcapsule slurry was removed by vacuum filtration in a Gooch filter crucible (porosity 4) and the powder was dried. The recovered solid was ground in an IKA tube-mill control grinder for 30 seconds. The resulting paste (fragrance oil + polymer shell) was suspended in 300 mL of ethyl acetate and the mixture was stirred at room temperature for 1 hour. The solid was recovered by vacuum filtration in a Gooch filter crucible (porosity 4). This extraction process was repeated five times to remove maximum fragrance oil from the shell. The powder was dried under vacuum (10 mBar) at 50 °C until the weight of the polymer was constant, monitored gravimetrically. The resulting powder was ground in an IKA tube-mill control grinder for 1 minute 30 seconds, suspended in demineralized water (0.5% w / w) and stirred at 300 RPM for 24 hours at room temperature. The water was removed by vacuum filtration in a Gooch filter crucible (porosity 4) and the powder was dried at room temperature for 2.5 days, followed by drying overnight under vacuum (10 mBar) at 50°C. Finally, the resulting powder was ground in an IKA tube-mill control grinder for 1 min 30 s and extracted five more times with ethyl acetate as described above. The final powder was dried overnight under vacuum (10 mBar) at 50°C. To ensure that the total amount of fragrance was removed, samples were analyzed by GC pyrolysis and submitted to biodegradation measurements according to OECD method 301F.

[0281] The biodegradability of the shell analyzed as an example was greater than 40% after a 60 day test.

[0282] Example 9 Preparation of spray-dried microcapsules Emulsions A through E are prepared having the following components:

[0283] [Table 10-1] [Table 10-2]

[0284] [Table 11-1] [Table 11-2]

[0285] The ingredients of the polymer matrix (maltodextrin and capsul™, or capsul™, citric acid and tripotassium citrate) are added to 45-50°C water until completely dissolved.

[0286] For Emulsion D, non-encapsulated fragrance C is added to the water phase.

[0287] The microcapsule slurry is added to the resulting mixture, which is then gently mixed at 25° C. (room temperature).

[0288] Granular powders A-E are prepared by spray drying emulsions A-E using a Sodeva Spray Dryer (supplied from France) with the air inlet temperature set at 215° C. and the throughput set at 500 ml per hour. The air outlet temperature is 105° C. The emulsions before atomization are at room temperature.

[0289] Example 10 Liquid fragrance enhancer composition A sufficient amount of the exemplary microcapsules is weighed out and mixed into a liquid fragrance enhancer to add the equivalent of 0.2% perfume.

[0290] [Table 12]

[0291] Prepare various ringing gel compositions according to the following protocol (Compositions 1-6).

[0292] In the first step, the aqueous phase (water), the solvent (propylene glycol), if present, and the surfactant are mixed under magnetic stirring at 300 rpm at room temperature for 5 minutes.

[0293] In the second step, the linker is dissolved in the hydrophobic active ingredient (fragrance) at room temperature under magnetic stirring at 300 rpm. The resulting mixture is mixed for 5 minutes.

[0294] The aqueous and oil phases are then mixed at room temperature for 5 minutes to form a clear or milky ringing gel.

[0295] Example 11 Liquid detergent composition A sufficient amount of the exemplary microcapsules is weighed out and mixed into a liquid detergent to add the equivalent of 0.2% perfume.

[0296] [Table 13]

[0297] Example 12 Unit Dose Formulations A sufficient amount of the exemplary microcapsules is weighed out and mixed into a unit dose formulation to add the equivalent of 0.2% flavor.

[0298] The unit dose formulation can be contained in a PVOH (polyvinyl alcohol) film.

[0299] [Table 14]

[0300] Example 13 Powder detergent composition A sufficient amount of the exemplary microcapsules is weighed out and mixed into a powder detergent composition to add the equivalent of 0.2% perfume.

[0301] [Table 15]

[0302] Example 14 Concentrated all-purpose cleaner composition A sufficient amount of the exemplary microcapsules is weighed and mixed into a concentrated all-purpose cleaner composition to add the equivalent of 0.2% fragrance.

[0303] [Table 16]

[0304] Example 15 Solid fragrance enhancer composition The following compositions are prepared:

[0305] [Table 17]

[0306] [Table 18]

[0307] Example 16 Shampoo Composition A sufficient amount of the exemplary microcapsules is weighed out and mixed into a shampoo composition to add the equivalent of 0.2% fragrance.

[0308] [Table 19]

[0309] Polyquaternium-10 is dispersed in water. The remaining ingredients of Phase A are mixed separately by adding them in order with thorough mixing after each addition. This premix is ​​then added to the Polyquaternium-10 dispersion and mixed for 5 minutes. Phase B and premixed Phase C (Monomuls 90L-12 heat melted in Texapon NSO IS) are then added. The mixture is mixed well. Phase D and Phase E are then added with stirring. The pH is adjusted to pH 5.5-6.0 with citric acid solution.

[0310] Example 17 Shampoo Composition A sufficient amount of the exemplary microcapsules is weighed out and mixed into a shampoo composition to add the equivalent of 0.2% fragrance.

[0311] [Table 20-1] [Table 20-2]

[0312] The premix containing guar hydroxypropyltrimonium chloride and polyquaternium-10 is added to the water and tetrasodium EDTA while mixing. When the mixture is uniform, NaOH is added. Phase C ingredients are then added and the mixture is heated to 75°C. Phase D ingredients are added and mixed until uniform. Heat is removed and the mixture is allowed to cool to room temperature. At 45°C, the final viscosity is adjusted with 25% NaCl solution while mixing Phase E ingredients, and the pH is adjusted to 5.5-6 with 10% NaOH solution.

[0313] Example 18 Rinse-off hair composition A sufficient amount of the exemplary microcapsules is weighed out and mixed into a rinse-off composition to add the equivalent of 0.2% perfume.

[0314] [Table 21]

[0315] The ingredients of Phase A are mixed until a homogenous mixture is obtained. The Tylose is completely dissolved. The mixture is then heated to 70-75°C. The ingredients of Phase B are combined and melted at 70-75°C. The ingredients of Phase B are then added to Phase A with good mixing and mixing is continued until the mixture has cooled to 60°C. The ingredients of Phase C are then added with mixing and mixing is continued until the mixture has cooled to 40°C. The pH is adjusted to pH 3.5-4.0 with citric acid solution.

[0316] Example 19 Antiperspirant spray anhydrous composition A sufficient amount of the exemplary microcapsules is weighed and mixed into an antiperspirant spray anhydrous composition to add the equivalent of 0.2% perfume.

[0317] [Table 22]

[0318] Using a high speed stirrer, add the silica and quaternium-18-hectorite to the mixture of isopropyl myristate and cyclomethicone. After complete swelling, add the aluminum chlorohydrate in small portions under stirring until the mixture is homogenous and free of lumps. Fill an aerosol can with 25% of the suspension and 75% of propane / butane (2.5 bar).

[0319] Example 20 Antiperspirant spray emulsion composition A sufficient amount of the exemplary microcapsules is weighed and mixed into an antiperspirant spray emulsion composition to add the equivalent of 0.2% perfume.

[0320] [Table 23]

[0321] The ingredients of Part A and Part B are weighed separately. The ingredients of Part A are heated to 60°C and the ingredients of Part B are heated to 55°C. The ingredients of Part B are poured into A in small portions with continuous stirring. The mixture is stirred well until it reaches room temperature. The ingredients of Part C are then added. The emulsion is mixed and introduced into an aerosol can. The propellant is crimped and added.

[0322] Aerosol filling: 30% Emulsion: 70% Propane / Butane 2.5bar Example 21 Deodorant spray composition A sufficient amount of the exemplary microcapsules is weighed and mixed into an antiperspirant deodorant spray composition to add the equivalent of 0.2% fragrance.

[0323] [Table 24]

[0324] All ingredients are mixed and dissolved according to the order in Table 24. Aerosol cans are then filled, crimped and propellant is added (aerosol fill: 40% active solution: 60% propane / butane 2.5 bar).

[0325] Example 22 Antiperspirant roll-on emulsion composition A sufficient amount of the exemplary microcapsules is weighed and mixed into an antiperspirant roll-on emulsion composition to add the equivalent of 0.2% perfume.

[0326] [Table 25]

[0327] Parts A and B are heated separately to 75°C, Part A is added to Part B under stirring, and the mixture is homogenized for 10 minutes. The mixture is then cooled under stirring, and Part C is added slowly with stirring when the mixture reaches 45°C, and Part D is added slowly with stirring when the mixture reaches 35°C. The mixture is then cooled to room temperature.

[0328] Example 23 Antiperspirant roll-on composition A sufficient amount of the exemplary microcapsules is weighed and mixed into an antiperspirant roll-on composition to add the equivalent of 0.2% perfume.

[0329] [Table 26]

[0330] The ingredients of Part B are mixed in a container and then the ingredients of Part A are added. Part C is then dissolved in Parts A and B. Along with the fragrance, 1 part Cremophor RH40 for every 1 part fragrance is added with good mixing.

[0331] Example 24 Antiperspirant roll-on composition A sufficient amount of the exemplary microcapsules is weighed and mixed into an antiperspirant roll-on emulsion composition to add the equivalent of 0.2% perfume.

[0332] [Table 27]

[0333] Prepare Part A by sprinkling hydroxyethyl cellulose into water in small portions while stirring rapidly with a turbine. Continue stirring until the hydroxyethyl cellulose is completely swollen and a clear gel is obtained. Then pour Part B into Part A in small portions while continuing to stir until the mixture is homogenous. Add Part C.

[0334] Example 25 Alcohol-free deodorant pump A sufficient amount of the exemplified microcapsules is weighed out and mixed into the following composition to add the equivalent of 0.2% fragrance.

[0335] [Table 28]

[0336] All ingredients are mixed in the order listed and the mixture is heated slightly to dissolve the cetyl lactate.

[0337] Example 26 Deodorant pump containing alcohol A sufficient amount of the exemplified microcapsules is weighed out and mixed into the following composition to add the equivalent of 0.2% fragrance.

[0338] [Table 29]

[0339] Mix the ingredients of Part B. Dissolve the ingredients of Part A in the order shown and pour into Part B.

[0340] Example 27 Talc Compound A sufficient amount of granules A to E is weighed out and mixed and introduced into a standard talc base: 100% talc, very slight characteristic odor, white powder, supplier: LUZENAC, and an equivalent amount of 0.2% flavor is added.

[0341] Example 28 Shower gel reference A sufficient amount of the exemplified microcapsules is weighed out and mixed into the following composition to add the equivalent of 0.2% fragrance.

[0342] [Table 30]

[0343] Mix the ingredients and adjust the pH to 6-6.3 (viscosity: 4500 cPo ± 1500 cPo (Brookfield RV / spindle #4 / 20 RPM)).

[0344] Example 29 Shower gel composition A sufficient amount of the exemplified microcapsules is weighed out and mixed into the following composition to add the equivalent of 0.2% fragrance.

[0345] [Table 31]

[0346] The ingredients are mixed and the pH adjusted to 4.5 (viscosity: 3000 cPo ± 1500 cPo (Brookfield RV / spindle #4 / 20 RPM)).

[0347] Example 30 Shower gel composition A sufficient amount of the exemplified microcapsules is weighed out and mixed into the following composition to add the equivalent of 0.2% fragrance.

[0348] [Table 32]

[0349] The ingredients are mixed and the pH is adjusted to 4.5 (viscosity: 4000 cPo ± 1500 cPo (Brookfield RV / spindle #4 / 20 RPM)).

[0350] Example 31 Hand Dishwash A sufficient amount of the exemplified microcapsules is weighed out and mixed into the following composition to add the equivalent of 0.2% fragrance.

[0351] [Table 33]

[0352] Mix water with sodium hydroxide and diethanolamide. Add LAS. After LAS is neutralized, add remaining ingredients. Check pH (=7-8) and adjust if necessary.

[0353] Example 32 Toothpaste formulations A sufficient amount of microcapsule slurry M (prepared according to the protocol disclosed in Example 1 except that menthol flavor is encapsulated) is weighed and mixed into the following composition to add the equivalent of 0.2% flavor.

[0354] [Table 34]

[0355] Example 33 Dicalcium phosphate-based toothpaste formulations A sufficient amount of microcapsule slurry M (prepared according to the protocol disclosed in Example 1 except that menthol flavor is encapsulated) is weighed and mixed into the following composition to add the equivalent of 0.2% flavor.

[0356] [Table 35]

[0357] Example 34 Alcohol-free mouthwash formulation A sufficient amount of microcapsule slurry M (prepared according to the protocol disclosed in Example 1 except that menthol flavor is encapsulated) is weighed and mixed into the following composition to add the equivalent of 0.2% flavor.

[0358] [Table 36]

[0359] Example 35 Mouthwash formulations A sufficient amount of microcapsule slurry M (prepared according to the protocol disclosed in Example 1 except that menthol flavor is encapsulated) is weighed and mixed into the following composition to add the equivalent of 0.2% flavor.

[0360] [Table 37]

Claims

1. A core-shell microcapsule, a core comprising a hydrophobic material, preferably a perfume oil; a polymer shell comprising a protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, broad bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof; A core-shell microcapsule comprising:

2. 2. The core-shell microcapsule of claim 1, wherein the polymer shell comprises a material selected from the group consisting of polyamide, polyurea, polyurethane, polyester, polyacrylate, polysiloxane, polycarbonate, polysulfonamide, polymers of urea and formaldehyde, melamine and formaldehyde, melamine and urea or melamine and glyoxal, and mixtures thereof.

3. The core-shell microcapsule of claim 1 , wherein the polymer shell is a polyamide-based shell.

4. 4. The core-shell microcapsule of claim 3, wherein the polyamide-based shell is obtained from the reaction of an acyl chloride with at least one amino compound.

5. 4. The core-shell microcapsule of claim 3, wherein the polyamide-based shell is obtained from the reaction of an acyl chloride with at least two amino compounds.

6. The amino compound may be cystamine, cystamine hydrochloride, cystine, cystine hydrochloride, cystine dialkyl ester, cystine dialkyl ester hydrochloride, xylylenediamine, 1,2-diaminocyclohexane, 1,4-diaminocyclohexane, polyetheramine, ethylenediamine, diethylenetriamine, spermine, spermidine, polyamidoamine (PAMAM), guanidine carbonate, chitosan, tris-(2-aminoethyl)amine, 3-aminopropyltriethoxysilane, 1,4-diaminobutane, 2,2-dimethyl-1,3-propanediamine, 1,3-diaminopentane, 1,2-diaminopropane, triethylenetetramine, 1,3-diaminopropane; urea; ethylenediamine; 6. The core-shell microcapsules according to claim 4 or 5, wherein the amino compound is selected from the group consisting of polyethylene urea; aminoguanidine bicarbonate; 1-(2-aminoethyl)imidazolidin-2-one; N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine; N1-(2-aminoethyl)-N1-dodecyl-1,2-ethanediamine; aminoethylethanolamine; N1-(3-aminopropyl)propane-1,3-diamine, polyethyleneimine, amino compounds such as L-lysine, L-arginine, L-histidine, L-tryptophan, L-serine, L-glutamine, L-threonine, L-leucine, and / or their derived oligomers and polymers, and mixtures thereof.

7. 2. The core-shell microcapsule of claim 1, wherein the protein is selected from the group consisting of potato protein, chickpea protein, pea protein, and mixtures thereof.

8. The acyl chloride is represented by formula (I) 【Chemical 1】 [In the formula, n is an integer varying from 1 to 8, preferably from 1 to 6, more preferably from 1 to 4; X is (i) to (xi) 【Chemistry 2】 (n+1)-valent C optionally containing at least one group selected from ２ ~C ４５ is a hydrocarbon group, R is a hydrogen atom or an alkyl group such as a methyl or ethyl group, preferably a hydrogen atom.

6. The core-shell microcapsule according to claim 4 or 5, wherein the compound is:

9. 5. The core-shell microcapsule of claim 4, wherein the polyamide-based shell is obtained from the reaction of an acyl chloride with at least one amino compound, and the at least one amino compound is L-lysine.

10. 1. A method for preparing a core-shell microcapsule slurry, comprising: a) preparing an oil phase comprising a hydrophobic material, preferably a perfume, to form an oil phase; b) dispersing the oil phase obtained in step a) in an aqueous phase to form an oil-in-water emulsion; c) carrying out a curing step to form microcapsules in the form of a slurry; Including, adding a multifunctional monomer to the oil phase and / or the water phase; A protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, fava bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof is added to the oil phase and / or the aqueous phase.

11. 11. The method of claim 10, wherein the multifunctional monomer is selected from the group consisting of at least one acyl chloride, polyisocyanate, polyanhydride, polyepoxide, acrylate monomer, polyalkoxysilane, and mixtures thereof.

12. a) preparing an oil phase comprising an acyl chloride and a hydrophobic material, preferably a fragrance, to form an oil phase; b) dispersing the oil phase obtained in step a) in an aqueous phase to form an oil-in-water emulsion; c) carrying out a curing step to form microcapsules in the form of a slurry; Including, adding at least one amino compound to the aqueous phase prior to the formation of the oil-in-water emulsion and / or to the oil-in-water emulsion obtained after step b), 12. The method of claim 10 or 11, wherein a protein selected from the group consisting of potato protein, chickpea protein, pea protein, algae protein, faba bean protein, barley protein, oat protein, wheat gluten protein, lupin protein and mixtures thereof is added to the oil phase and / or the aqueous phase.

13. A fragrance composition comprising: (i) the microcapsules of claim 1, wherein the hydrophobic active ingredient comprises a perfume. (ii) at least one ingredient selected from the group consisting of a perfume carrier and a perfume base; (iii) optionally at least one perfume adjuvant A fragrance composition comprising:

14. 1. A consumer product comprising: - a personal care active base; - the microcapsules according to claim 1 or the fragrance composition according to claim 13; Including, the consumer product is in the form of a personal care composition; consumer products.

15. 1. A consumer product comprising: - a home or fabric care active base, - the microcapsules according to claim 1 or the fragrance composition according to claim 13; Including, the consumer product is in the form of a home care or fabric care composition; consumer products.

Images